Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches.
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2024 · third_quarter · 3A
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries. Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion. Contacts in support of the VA Abortion Transparency Act of 2024 (H.R.8029/S.4128) to require abortion numbers from the VA.
Contacts in opposition to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services. Contacts in support of Van Duyne Amendment (#55) to NDAA (H.R. 8070) to defund the DOD memorandum.
Source: Senate LDA
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "National Emission Standards for Hazardous Air Pollutants: Lime Manufacturing Plants Technology Review".
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. These include: -- opposition to signing of House Discharge Petition No. 6 (Pressley), filed July 18, 2023, seeking discharge of H.J. Res. 25. -- opposition to S.J. Res. 39 (Gillibrand) and H.J. Res. 82 (Bush), expressing the non-binding "sense of Congress" that the Equal Rights Amendment has been ratified and that the Archivist "should" publish/certify it. -- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes by certain members of Congress and others to pressure the Archivist of the United States to certify the ERA in contravention of multiple federal court rulings. -- support for Senate Resolution 107 (Hyde-Smith), expressing the sense of the Senate that Congress lacks power to act on a constitutional amendment resolution after submitting it to the states, or to revive an expired amendment proposal.
Removing the deadline for the ratification of the equal rights amendment.
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. These include: -- opposition to signing of House Discharge Petition No. 6 (Pressley), filed July 18, 2023, seeking discharge of H.J. Res. 25. -- opposition to S.J. Res. 39 (Gillibrand) and H.J. Res. 82 (Bush), expressing the non-binding "sense of Congress" that the Equal Rights Amendment has been ratified and that the Archivist "should" publish/certify it. -- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes by certain members of Congress and others to pressure the Archivist of the United States to certify the ERA in contravention of multiple federal court rulings. -- support for Senate Resolution 107 (Hyde-Smith), expressing the sense of the Senate that Congress lacks power to act on a constitutional amendment resolution after submitting it to the states, or to revive an expired amendment proposal.
Expressing the sense of Congress that the article of amendment commonly known as the "Equal Rights Amendment" has been validly ratified and is enforceable as the Twenty-Eighth Amendment to the United States Constitution, and the Archivist of the United States must certify and publish the Equal Rights Amendment as the Twenty-Eighth Amendment without delay.
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. These include: -- opposition to signing of House Discharge Petition No. 6 (Pressley), filed July 18, 2023, seeking discharge of H.J. Res. 25. -- opposition to S.J. Res. 39 (Gillibrand) and H.J. Res. 82 (Bush), expressing the non-binding "sense of Congress" that the Equal Rights Amendment has been ratified and that the Archivist "should" publish/certify it. -- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes by certain members of Congress and others to pressure the Archivist of the United States to certify the ERA in contravention of multiple federal court rulings. -- support for Senate Resolution 107 (Hyde-Smith), expressing the sense of the Senate that Congress lacks power to act on a constitutional amendment resolution after submitting it to the states, or to revive an expired amendment proposal.
Women’s Public Health and Safety Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Women’s Public Health and Safety Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Women’s Public Health and Safety Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Women’s Public Health and Safety Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Women’s Public Health and Safety Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Women’s Public Health and Safety Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Women’s Health Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Women’s Health Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Women’s Health Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Women’s Health Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Women’s Health Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Women’s Health Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Heartbeat Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Heartbeat Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Heartbeat Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Heartbeat Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Heartbeat Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Heartbeat Protection Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Born-Alive Abortion Survivors Protection Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Born-Alive Abortion Survivors Protection Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Born-Alive Abortion Survivors Protection Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Born-Alive Abortion Survivors Protection Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Born-Alive Abortion Survivors Protection Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Born-Alive Abortion Survivors Protection Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Title X Abortion Provider Prohibition Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Title X Abortion Provider Prohibition Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Title X Abortion Provider Prohibition Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Title X Abortion Provider Prohibition Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Title X Abortion Provider Prohibition Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Title X Abortion Provider Prohibition Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Defund Planned Parenthood Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Protecting Life and Integrity in Research Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Protecting Life and Integrity in Research Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Protecting Life and Integrity in Research Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Protecting Life and Integrity in Research Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Protecting Life and Integrity in Research Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Protecting Life and Integrity in Research Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Teleabortion Prevention Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Teleabortion Prevention Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Teleabortion Prevention Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Teleabortion Prevention Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Teleabortion Prevention Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Teleabortion Prevention Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Protecting Life on College Campus Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Protecting Life on College Campus Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Protecting Life on College Campus Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Protecting Life on College Campus Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Protecting Life on College Campus Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Protecting Life on College Campus Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Human Trafficking and Exploitation Prevention Training Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Human Trafficking and Exploitation Prevention Training Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Human Trafficking and Exploitation Prevention Training Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Human Trafficking and Exploitation Prevention Training Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Human Trafficking and Exploitation Prevention Training Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Human Trafficking and Exploitation Prevention Training Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Recognizing Victims of Illicit Fentanyl Poisoning Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Recognizing Victims of Illicit Fentanyl Poisoning Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Recognizing Victims of Illicit Fentanyl Poisoning Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Recognizing Victims of Illicit Fentanyl Poisoning Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Recognizing Victims of Illicit Fentanyl Poisoning Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Recognizing Victims of Illicit Fentanyl Poisoning Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Pregnant Students’ Rights Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Pregnant Students’ Rights Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Pregnant Students’ Rights Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Pregnant Students’ Rights Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Pregnant Students’ Rights Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Pregnant Students’ Rights Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Supporting Pregnant and Parenting Women and Families Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Supporting Pregnant and Parenting Women and Families Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Supporting Pregnant and Parenting Women and Families Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Supporting Pregnant and Parenting Women and Families Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Supporting Pregnant and Parenting Women and Families Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Supporting Pregnant and Parenting Women and Families Act
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023
Client: NATIONAL RIGHT LIFE COMMITTEE · Firm: NATIONAL RIGHT TO LIFE COMMITTEE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Contacts in support of proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation," 88 FR 12875 (March 1, 2023), (RIN): 1117-AB40, Docket ID DEA-407 due to impact of assisted suicide drugs. Contacts regarding vending machine dispensing of chemical abortion drugs.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability. Contacts in support of Simon's Law requiring providers to inform at least one parent or legal guardian of a physicians intent to institute a DNR both orally and in writing and providing either parent with authority to refuse consent for a DNR. Contacts in regards to legislation and resolutions on IVF, to the extend they might impact abortion policy. No position taken. Contacts in opposition to the so-called Right to IVF Act (S.4445) due to a definition of assisted reproductive technology that is so expansive, it can be reasonably interpreted to impose a new right to human cloning, the genetic engineering of embryos including human-animal hybrids, or chimeras. Contacts in opposition to the so-called "Right to Contraception Act" (S. 4381) which goes far beyond contraception (NRLC takes no position on contraception), and includes provisions related to the funding of abortion providers and contains language that could expand the use of drugs to induce an abortion weeks or months into a pregnancy.
Contan=cts in opposition to propose regulations. Regulations to implement the Pregnant Workers Fairness Act,88 Fed. Reg 54714(August 11, 2023),(RIN):3046-AB30)due to requirement that employees with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts regarding PEPFAR reauthorization over whether federal funds are going to funding recipients who also promote abortion. Contacts regarding MOC letter urging the WHO to refrain from adding the Center for Reproductive Rights as a health organization with special status.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Contacts in opposition to proposed regulations, Regulations to Implement the Pregnant Workers Fairness Act, 88 Fed. Reg 54714 (August 11, 2023), (RIN): 3046-AB30) due to requirement that employers with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave.
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY25 appropriations. Contacts in support of new riders including those related regulation of chemical abortion drugs, paying for elective health abortions at Veterans Affairs, and others related to defunding the Department of Defense policy to pay for abortion-related travel. Contacts in regard to certain earmarks to facilities providing abortion.
Filing targets: Drug Enforcement Administration (DEA), Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2024 · third_quarter · 3A
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries. Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion. Contacts in support of the VA Abortion Transparency Act of 2024 (H.R.8029/S.4128) to require abortion numbers from the VA.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability. Contacts in support of Simon's Law requiring providers to inform at least one parent or legal guardian of a physicians intent to institute a DNR both orally and in writing and providing either parent with authority to refuse consent for a DNR. Contacts in regards to legislation and resolutions on IVF, to the extend they might impact abortion policy. No position taken. Contacts in opposition to the so-called Right to IVF Act (S.4445) due to a definition of assisted reproductive technology that is so expansive, it can be reasonably interpreted to impose a new right to human cloning, the genetic engineering of embryos including human-animal hybrids, or chimeras. Contacts in opposition to the so-called "Right to Contraception Act" (S. 4381) which goes far beyond contraception (NRLC takes no position on contraception), and includes provisions related to the funding of abortion providers and contains language that could expand the use of drugs to induce an abortion weeks or months into a pregnancy.
Contacts in opposition to proposed regulations, Regulations to Implement the Pregnant Workers Fairness Act, 88 Fed. Reg 54714 (August 11, 2023), (RIN): 3046-AB30) due to requirement that employers with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave.
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY25 appropriations. Contacts in support of new riders including those related regulation of chemical abortion drugs, paying for elective health abortions at Veterans Affairs, and others related to defunding the Department of Defense policy to pay for abortion-related travel. Contacts in regard to certain earmarks to facilities providing abortion.
Contan=cts in opposition to propose regulations. Regulations to implement the Pregnant Workers Fairness Act,88 Fed. Reg 54714(August 11, 2023),(RIN):3046-AB30)due to requirement that employees with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave
Contacts in opposition to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services. Contacts in support of Van Duyne Amendment (#55) to NDAA (H.R. 8070) to defund the DOD memorandum.
Contacts regarding PEPFAR reauthorization over whether federal funds are going to funding recipients who also promote abortion. Contacts regarding MOC letter urging the WHO to refrain from adding the Center for Reproductive Rights as a health organization with special status.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Contacts in support of proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation," 88 FR 12875 (March 1, 2023), (RIN): 1117-AB40, Docket ID DEA-407 due to impact of assisted suicide drugs. Contacts regarding vending machine dispensing of chemical abortion drugs.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Filing targets: Drug Enforcement Administration (DEA), Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2024 · third_quarter · Q3
Contacts in opposition to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services. Contacts in support of Van Duyne Amendment (#55) to NDAA (H.R. 8070) to defund the DOD memorandum.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability. Contacts in support of Simon's Law requiring providers to inform at least one parent or legal guardian of a physicians intent to institute a DNR both orally and in writing and providing either parent with authority to refuse consent for a DNR. Contacts in regards to legislation and resolutions on IVF, to the extend they might impact abortion policy. No position taken. Contacts in opposition to the so-called Right to IVF Act (S.4445) due to a definition of assisted reproductive technology that is so expansive, it can be reasonably interpreted to impose a new right to human cloning, the genetic engineering of embryos including human-animal hybrids, or chimeras. Contacts in opposition to the so-called "Right to Contraception Act" (S. 4381) which goes far beyond contraception (NRLC takes no position on contraception), and includes provisions related to the funding of abortion providers and contains language that could expand the use of drugs to induce an abortion weeks or months into a pregnancy.
Contacts in opposition to proposed regulations, Regulations to Implement the Pregnant Workers Fairness Act, 88 Fed. Reg 54714 (August 11, 2023), (RIN): 3046-AB30) due to requirement that employers with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Contacts in support of proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation," 88 FR 12875 (March 1, 2023), (RIN): 1117-AB40, Docket ID DEA-407 due to impact of assisted suicide drugs. Contacts regarding vending machine dispensing of chemical abortion drugs.
Contan=cts in opposition to propose regulations. Regulations to implement the Pregnant Workers Fairness Act,88 Fed. Reg 54714(August 11, 2023),(RIN):3046-AB30)due to requirement that employees with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries. Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion. Contacts in support of the VA Abortion Transparency Act of 2024 (H.R.8029/S.4128) to require abortion numbers from the VA.
Contacts regarding PEPFAR reauthorization over whether federal funds are going to funding recipients who also promote abortion. Contacts regarding MOC letter urging the WHO to refrain from adding the Center for Reproductive Rights as a health organization with special status.
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY25 appropriations. Contacts in support of new riders including those related regulation of chemical abortion drugs, paying for elective health abortions at Veterans Affairs, and others related to defunding the Department of Defense policy to pay for abortion-related travel. Contacts in regard to certain earmarks to facilities providing abortion.
Filing targets: Drug Enforcement Administration (DEA), Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2024 · third_quarter · Q3
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY25 appropriations. Contacts in support of new riders including those related regulation of chemical abortion drugs, paying for elective health abortions at Veterans Affairs, and others related to defunding the Department of Defense policy to pay for abortion-related travel. Contacts in regard to certain earmarks to facilities providing abortion.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability. Contacts in support of Simon's Law requiring providers to inform at least one parent or legal guardian of a physicians intent to institute a DNR both orally and in writing and providing either parent with authority to refuse consent for a DNR. Contacts in regards to legislation and resolutions on IVF, to the extend they might impact abortion policy. No position taken. Contacts in opposition to the so-called Right to IVF Act (S.4445) due to a definition of assisted reproductive technology that is so expansive, it can be reasonably interpreted to impose a new right to human cloning, the genetic engineering of embryos including human-animal hybrids, or chimeras. Contacts in opposition to the so-called "Right to Contraception Act" (S. 4381) which goes far beyond contraception (NRLC takes no position on contraception), and includes provisions related to the funding of abortion providers and contains language that could expand the use of drugs to induce an abortion weeks or months into a pregnancy.
Contan=cts in opposition to propose regulations. Regulations to implement the Pregnant Workers Fairness Act,88 Fed. Reg 54714(August 11, 2023),(RIN):3046-AB30)due to requirement that employees with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries. Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion. Contacts in support of the VA Abortion Transparency Act of 2024 (H.R.8029/S.4128) to require abortion numbers from the VA.
Contacts in support of proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation," 88 FR 12875 (March 1, 2023), (RIN): 1117-AB40, Docket ID DEA-407 due to impact of assisted suicide drugs. Contacts regarding vending machine dispensing of chemical abortion drugs.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Contacts in opposition to proposed regulations, Regulations to Implement the Pregnant Workers Fairness Act, 88 Fed. Reg 54714 (August 11, 2023), (RIN): 3046-AB30) due to requirement that employers with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave.
Contacts in opposition to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services. Contacts in support of Van Duyne Amendment (#55) to NDAA (H.R. 8070) to defund the DOD memorandum.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts regarding PEPFAR reauthorization over whether federal funds are going to funding recipients who also promote abortion. Contacts regarding MOC letter urging the WHO to refrain from adding the Center for Reproductive Rights as a health organization with special status.
Filing targets: Drug Enforcement Administration (DEA), Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2024 · second_quarter · Q2
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries. Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion. Contacts in support of the VA Abortion Transparency Act of 2024 (H.R.8029/S.4128) to require abortion numbers from the VA.
Contacts in opposition to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services. Contacts in support of Van Duyne Amendment (#55) to NDAA (H.R. 8070) to defund the DOD memorandum.
Contacts in opposition to proposed regulations, Regulations to Implement the Pregnant Workers Fairness Act, 88 Fed. Reg 54714 (August 11, 2023), (RIN): 3046-AB30) due to requirement that employers with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts regarding PEPFAR reauthorization over whether federal funds are going to funding recipients who also promote abortion. Contacts regarding MOC letter urging the WHO to refrain from adding the Center for Reproductive Rights as a health organization with special status.
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY25 appropriations. Contacts in support of new riders including those related regulation of chemical abortion drugs, paying for elective health abortions at Veterans Affairs, and others related to defunding the Department of Defense policy to pay for abortion-related travel. Contacts in regard to certain earmarks to facilities providing abortion.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability. Contacts in support of Simon's Law requiring providers to inform at least one parent or legal guardian of a physicians intent to institute a DNR both orally and in writing and providing either parent with authority to refuse consent for a DNR. Contacts in regards to legislation and resolutions on IVF, to the extend they might impact abortion policy. No position taken. Contacts in opposition to the so-called Right to IVF Act (S.4445) due to a definition of assisted reproductive technology that is so expansive, it can be reasonably interpreted to impose a new right to human cloning, the genetic engineering of embryos including human-animal hybrids, or chimeras. Contacts in opposition to the so-called "Right to Contraception Act" (S. 4381) which goes far beyond contraception (NRLC takes no position on contraception), and includes provisions related to the funding of abortion providers and contains language that could expand the use of drugs to induce an abortion weeks or months into a pregnancy.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Contacts in support of proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation," 88 FR 12875 (March 1, 2023), (RIN): 1117-AB40, Docket ID DEA-407 due to impact of assisted suicide drugs. Contacts regarding vending machine dispensing of chemical abortion drugs.
Filing targets: Drug Enforcement Administration (DEA), Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2024 · first_quarter · Q1
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY24 appropriations. Contacts in support of new riders including those related regulation of chemical abortion drugs, paying for elective health abortions at Veterans Affairs, and others related to defunding the Department of Defense policy to pay for abortion-related travel. Contacts in regard to certain earmarks to facilities providing abortion. Similar activities related to FY25 appropriations.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2023 · fourth_quarter · Q4
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation to establish a Federal tax credit for pregnancy centers.
Contacts in opposition to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services. Contacts in support of a motion to table from Sen. Ernst (R-IA) for the purpose of making in order a vote on a motion to recommit the Conference Report on the NDAA to prohibit the Secretary of Defense from paying for or reimbursing expenses relating to elective abortion.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2023 · third_quarter · Q3
Contacts in support of proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation," 88 FR 12875 (March 1, 2023), (RIN): 1117-AB40, Docket ID DEA-407 due to impact of assisted suicide drugs. Contacts regarding vending machine dispensing of chemical abortion drugs.
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries. Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2023 · second_quarter · Q2
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability. Contacts in opposition to proposed rule, Safeguarding the Rights of Conscience as Protected by Federal Statutes, 88 Fed. Reg. 820 (January 5, 2023), (RIN): 0945-AA18, Docket ID 2022-28505) as well as contacts related to various pieces of conscience legislation.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2023 · first_quarter · Q1
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. These include: -- opposition to S.J. Res. 4 (Cardin) and H.J. Res. 25 (Pressley), resolutions purporting by multiple unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J. Res. 208 of the 92nd Congress, and to declare the long-expired 1972 Equal Rights Amendment to be part of the U.S. Constitution. -- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes by certain members of Congress and others to pressure the Archivist of the United States to certify the ERA in contravention of federal court rulings. -- support for Senate Resolution 107 (Hyde-Smith), expressing the sense of the Senate that Congress lacks power to act on a constitutional amendment resolution after submitting it to the states, or to revive an expired amendment proposal. Contacts of advisory and informational nature regarding the nomination of Colleen Shogan, Ph.D., as Archivist of the United States (PN 68), with respect to the status of the Equal Rights Amendment, and relating to the handling of Freedom of Information Act (FOIA) requests by the National Archives and Records Administration. No position taken on confirmation during this reporting period.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2022 · fourth_quarter · Q4
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections. Contacts in support of enforcing the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance, including support for a CRA (S.J.Res. 43/H.J.Res. 79)regarding Biden administration regulation. Contacts in regards to the Cures 2.0 legislation (H.R. 6000) with respect to abortion. Contacts in support of legislation (not introduces) to prohibit abortions from being counted as an eligible medical expense for Health Savings Accounts.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2022 · third_quarter · Q3
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regards to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regards to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs. Contacts in regards to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (S. 4868/H.R. 8851 Providing for Life Act, H.R. 8384/S.4541 Standing with Moms Act, and others). Contacts in regards to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in regards to the Central American Women and Children Protection Act of 2021 (H.R.4017). No position taken.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2022 · second_quarter · Q2
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. This includes: -- opposition to H.J. Res. 17 and S.J. Res. 1, resolutions purporting by multiple unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J.Res. 208 of the 92nd Congress. -- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes to pressure the Archivist of the United States to certify the ERA in contravention of federal court rulings and the legal positions of the Department of Justice. -- opposition to H.Res. 891 (Speier), declaring "the sense of the House of Representatives" that the Equal Rights Amendment is part of the Constitution. -- opposition to H.J. Res. 28 (Maloney), "Proposing an amendment to the Constitution of the United States relative to equal rights for men and women." Contacts in opposition to the nomination of Ketanji Brown Jackson to the Supreme Court.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2022 · first_quarter · Q1
Contacts in opposition to the Equality Act (H.R. 5/S. 393) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in opposition to the For the People Act of 2021 and Freedom to Vote Act (H.R. 1/S.1/S. 2093/S.2747/H.R. 5746/H.R. 2747 H.9/S.9) because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2022 (S.3537/H.R. 6505) which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of the No Abortion Bonds Act (H.R. 606) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers. Contacts in support of the Abortion is Not Health Care Act (S.124/H.R.380) to end the preferential tax treatment of abortion. Contacts in support of the Protecting Life in Health Savings Accounts Act (S. 125) to end the preferential tax treatment of abortion in health savings accounts.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2021 · fourth_quarter · Q4
Contacts in opposition to the Equality Act (H.R. 5/S. 393) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in opposition to the For the People Act of 2021 and Freedom to Vote Act (H.R. 1/S.1/S. 2093/S.2747/H.R. 5746/H.R. 2747) because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters.
Contacts in support of retaining all current pro-life appropriations riders in FY22 appropriations. Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations. Contacts in opposition to the "Build Back Better" reconciliation bill in current form due to funding of abortion in various healthcare programs, including a November 4, 2021 letter to the House on H.R. 5376. Contacts regarding NDAA (the National Defense Authorization Act) related to the funding of abortion.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2021 · third_quarter · Q3
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. This includes opposition to H.J. Res. 17 and S.J. Res. 1, resolutions purporting by compound unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J.Res. 208 of the 92nd Congress. This also includes opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional impediments to resuscitation of the Equal Rights Amendment submitted to the states in 1972. Contacts in opposition to H.J. Res. 28 (Maloney), "Proposing an amendment to the Constitution of the United States relative to equal rights for men and women." Contacts in opposition to H.R. 51 to grant statehood to D.C. due to constitutional concerns. Additionally, if D.C. were to become a state, the predictable result will be tax funding of hundreds (if not more) of elective abortions in D.C. annually.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2021 · second_quarter · Q2
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123 ), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation (not introduced) to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620 ). No position taken. Contacts in opposition to the Paycheck Fairness Act (H.R. 7) because the legislation addresses discrimination based on sex, and there is no rule of construction that would make this legislation abortion-neutral, it is likely that it could be used to sue employers for a lack of elective abortion coverage. Letter sent to House April 13, 2021 and to the Senate June 8, 2021. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Letter sent to the House June 22, 2021.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2021 · first_quarter · Q1
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Child Tax Credit for Pregnant Moms Act (not introduced) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the child's first year of life. Contacts in support of the No Abortion Bonds Act (H.R. 606) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers. Contacts in support of the Abortion is Not Health Care Act (S.124/H.R.380) to end the preferential tax treatment of abortion. Contacts in support of the Protecting Life in Health Savings Accounts Act (S. 125) to end the preferential tax treatment of abortion in health savings accounts.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2020 · fourth_quarter · Q4
Contacts in support of retaining all current pro-life appropriations riders and funding levels in FY21 appropriations. Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts regarding administrative changes to Medicare part D requiring step therapy and drug price capping based on a look-back period as it would relate to the delay or denial of life-saving medication. Contacts in opposition to administrative changes to International Price Indexing as it would base drug prices off of international prices that utilize the quality-adjusted-life year which is used to deny treatment to patients with ongoing medical needs and persons with disabilities.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2020 · third_quarter · Q3
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2019 (H.R. 2266/ S.1150) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the childs first year of life. Contacts in support of the No Abortion Bonds Act to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers. Contacts regarding IRS guidance and preferential tax treatment of costs associated with elective abortion as well as of plans that cover elective abortion.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by Congress in March 1972, with a ratification deadline that expired in March 1979. This includes opposition to H.J. Res. 79 and S.J. Res. 6 (purporting by unconstitutional mechanisms to nullify the ratification deadline contained in the joint resolution submitted to the states in 1972). Opposition extends also to current text of H.J. Res 35 and S. J. Res. 15 (proposing re-submission of 1972 ERA language to the states, this time without a ratification deadline).
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2020 · second_quarter · Q2
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states in March 1972, with a ratification deadline that expired in March 1979. Includes opposition to H.J. Res. 79 and S.J. Res. 6 (purporting by unconstitutional mechanisms to nullify the ratification deadline contained in the joint resolution submitted to the states in 1972). Opposition extends also to current text of H.J. Res 35 and S. J. Res. 15 (proposing re-submission of 1972 ERA language to the states, this time without a ratification deadline). Opposition to H.R. 51, to admit D.C. as a state. If admitted as a state, D.C. would be able to fund elective abortions without restriction.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2019 (H.R. 2266/ S.1150) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the childs first year of life. Contacts in support of the No Abortion Bonds Act (H.R.219) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers. Contacts regarding IRS guidance and preferential tax treatment of costs associated with elective abortion as well as of plans that cover elective abortion.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2020 · first_quarter · Q1
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts regarding administrative changes to Medicare part D requiring step therapy and drug price capping based on a look-back period as it would relate to the delay or denial of life-saving medication.
Contacts in support of retaining all current pro-life appropriations riders and funding levels in FY20 appropriations. Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2019 · fourth_quarter · Q4
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2020 any Foreign Operations appropriations vehicle. Contacts in support of enforcement of the Protecting Life in Global Health Assistance policy. Contacts in support of retaining pro-life policies in the Organization of American States.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts regarding the Medicare Choices Empowerment and Protection Act (S. 618), to give beneficiaries and others online access to model advance directives that choose life-saving treatment, food and fluids equally with those that reject them in order to offset widespread efforts to nudge patients to agree to forego life-saving treatment. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts regarding administrative changes to Medicare part D requiring step therapy and drug price capping based on a look-back period as it would relate to the delay or denial of life-saving medication. Contacts regarding the Older Americans Act reauthorization as it would relate to the pressuring patients to reject treatment against their wishes. No position taken this quarter.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2019 · third_quarter · Q3
Contacts in opposition to the For the People Act of 2019 (H.R. 1) because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters. Letter sent to the House March 5, 2019. Contacts in opposition to the Equality Act (H.R. 5) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions, including a letter to the House dated May 9, 2019.
Contacts regarding advance care planning legislation (not introduced) to (1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, (2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, (3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act, (4) include oversight for grant approval for physician orders for life-sustaining treatment, and (5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in opposition to Medicare for All legislation (H.R. 1384 and S. 1129) because they mandate government coverage of abortions and are likely to require hospitals and doctors to perform abortion procedures. Contacts in opposition to the "Lower Drug Costs Now Act of 2019" (H.R. 3) because it will prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2019 · second_quarter · Q2
Contacts in support of including "Hyde Amendment" protections on any funds that might be appropriated, and to any efforts to stabilize Obamacare healthcare markets in the FY19 appropriations. Contacts in support of retaining all current pro-life appropriations riders in FY19 appropriations. Contacts in opposition to Fiscal 2020 Labor-HHS-Education Appropriations (H.R. 2740) because this legislation contains provisions that roll back current pro-life policies including the Protecting Statutory Conscience Rights in Health Care, the Title X family planning program administrative changes, and the Protecting Life in Global Health Assistance program including a letter to the house dated June 12, 2019. Contacts in opposition to Fiscal 2020 Financial Services and General Government Appropriations (H.R. 3351) because this legislation repeals the D.C. Hyde Amendment (sometimes called the Dornan Amendment) that has prevented tax-funded abortion in the District of Columbia for many years, including a letter to the House dated June 26, 2019.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2019 · first_quarter · Q1
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts regarding the Medicare Choices Empowerment and Protection Act (S. 618), to give beneficiaries and others online access to model advance directives that choose life-saving treatment, food and fluids equally with those that reject them in order to offset widespread efforts to nudge patients to agree to forego life-saving treatment. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that was submitted to the states in March 1972, with a ratification deadline that expired in March 1979. Opposition includes but is not limited to H.J. Res 35 and S. J. Res. 15 (proposing re-submission of 1972 ERA language to the states, this time without a ratification deadline); H.J. Res. 38 and H.J. Res. 6 (purporting to nullify the ratification deadline contained in the joint resolution submitted to the states in 1972, retroactively); and H. Res. 272 (expressing the view of the House of Representatives that the language of the 1972 ERA submission should be made part of the U.S. Constitution).
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2018 · fourth_quarter · Q4
Contacts in support of nomination of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Contacts is support timely committee and floor action on such nominees. Contacts pertaining to U.S. Supreme Court vacancy created by the resignation of Associate Justice Anthony Kennedy, and contacts in support of confirmation of Judge Brett Kavanaugh as successor Associate Justice (confirmed, Oct. 6, 2018). Consultations regarding legislation purporting to expand safe harbor for election-related speech by churches; no position on the legislation in the form introduced as the Free Speech Fairness Act (H.R. 781, S. 264).
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2019 continuing resolution and any other Foreign Operations appropriations vehicle. Contacts in opposition to S. 210, to remove the authority of the President to apply certain conditions to U.S. funds directed to foreign nongovernmental organizations. Response to inquiries regarding S. 1730, the Reach Every Mother and Child Act of 2017, which directs the President to establish a five-year strategy to achieve the goal of ending preventable child and maternal deaths globally and ensure healthy and productive lives by 2030. No position taken this quarter.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2018 · third_quarter · Q3
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2019 continuing resolution and any other Foreign Operations appropriations vehicle. Contacts in opposition to S. 210, to remove the authority of the President to apply certain conditions to U.S. funds directed to foreign nongovernmental organizations. Response to inquiries regarding S. 1730, the Reach Every Mother and Child Act of 2017, which directs the President to establish a five-year strategy to achieve the goal of ending preventable child and maternal deaths globally and ensure healthy and productive lives by 2030. No position taken this quarter.
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2018 · second_quarter · Q2
For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R. 4660, S. 2326), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 4712, S. 220), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the House dated January 16, 2018, and a letter to the House on Rule resolution H. Res. 694 dated January 17, 2018. (The House passed the bill on January 17, 2018.) Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 644, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding Defund Planned Parenthood Act (H.R.853) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Defund Planned Parenthood Act (H.R. 354, S.241), to deny for one year the availability of federal funds to Planned Parenthood affiliates or clinics that provide elective abortion. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in support of the Every Child is a Blessing Act (H.R. 684), to eliminate wrongful birth and wrongful life" lawsuits, when they arise under federal law or from claims involving health care services affecting interstate or foreign commerce. Contacts in response to inquiries regarding the Heartbeat Bill (H.R.490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts expressing support for addition of language to prevent subsidies for abortion and other pro-life components in proposed legislation to revise laws dealing with health benefits for Peace Corps volunteers (H.R. 2259 and S. 2286). Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Patients First Act (H.R. 2918) to require the federal National Institutes of Health to intensify research on types of stem-cell research that do not involve harming human embryos. Responses to inquiries regarding "Life at Conception Act" (H.R. 681, S. 231); nonsupport due to lack of clarity and erroneous legal premises. Contracts regarding abortion-pill reversal and informed consent requirements. Legislation not introduced. Responses to inquiries regarding H.R.4844, the Ultrasound Informed Consent Act, which provides that prior to an abortion, a provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting and display the ultrasound images so that the pregnant woman may view them. Inquiries regarding S.2266, the Abby Honold Act, regarding contract grantees to improve the handling of crimes of domestic violence, dating violence, sexual assault, and stalking. No position taken this quarter. Inquiries regarding H.R.767, the SOAR to Health and Wellness Act of 2018, related to contract grantees in regards to sex-trafficking victims. No position taken this quarter. Contacts regarding the Maternal Health Accountability Act (S. 1112 and H.R. 1318), related to reporting factors, contract grantee criteria, and potential issues surrounding recommending expansion of abortion access. No position taken this quarter. Contacts regarding the Veterans Mission Act of 2018, HR 5674, to give the Secretary wide authority to establish access standards for furnishingmedical services to covered veterans. No position taken this quarter. Contacts in support of a letter requesting that HHS issue new Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions.  
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2018 · first_quarter · Q1
For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (H.R. 36, S. 2311), to protect pain-capable unborn children beginning at 20 weeks fetal age including a letter to the Senate dated January 25, 2018. (On January 29, 2018, the Senate failed to invoke cloture to advance the legislation.) Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R. 4660, S. 2326), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 4712, S. 220), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the House dated January 16, 2018, and a letter to the House on Rule resolution H. Res. 694 dated January 17, 2018. (The House passed the bill on January 17, 2018.) Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 644, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding Defund Planned Parenthood Act (H.R.853) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Defund Planned Parenthood Act (H.R. 354, S.241), to deny for one year the availability of federal funds to Planned Parenthood affiliates or clinics that provide elective abortion. Activity on budget reconciliation bill pertaining to Planned Parenthood reported on BUD (Budget/Appropriations) page. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in support of the Every Child is a Blessing Act (H.R. 684), to eliminate wrongful birth and wrongful life" lawsuits, when they arise under federal law or from claims involving health care services affecting interstate or foreign commerce. Contacts in response to inquiries regarding the Heartbeat Bill (H.R.490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts expressing support for addition of language to prevent subsidies for abortion and other pro-life components in proposed legislation to revise laws dealing with health benefits for Peace Corps volunteers (H.R. 2259 and S. 2286). Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Patients First Act (H.R. 2918) to require the federal National Institutes of Health to intensify research on types of stem-cell research that do not involve harming human embryos. Responses to inquiries regarding "Life at Conception Act" (H.R. 681, S. 231); nonsupport due to lack of clarity and erroneous legal premises. Contracts regarding abortion-pill reversal and informed consent requirements. Legislation not introduced. Responses to inquiries regarding H.R.4844, the Ultrasound Informed Consent Act, which provides that prior to an abortion, a provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting and display the ultrasound images so that the pregnant woman may view them. Inquiries regarding S.2266, the Abby Honold Act, regarding contract grantees to improve the handling of crimes of domestic violence, dating violence, sexual assault, and stalking. No position taken this quarter. Inquiries regarding H.R.767, the SOAR to Health and Wellness Act of 2018, related to contract grantees in regards to sex-trafficking victims. No position taken this quarter.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2017 · fourth_quarter · Q4
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page. Contacts in support of the Medicare Choices Empowerment and Protection Act (S. 1530/H.R. 3181), to give beneficiaries and others online access to model advance directives that choose life-saving treatment, food and fluids equally with those that reject them in order to offset widespread efforts to nudge patients to agree to forego life-saving treatment.
Contacts regarding H.R.244, the Consolidated Appropriations Act of 2017, in regards to funding of certain providers of abortion; no position taken on this legislation (but supported extension of all existing pro-life limitations and provisions from previous appropriations periods). Contacts in support of language to the FY 2018 State, Foreign operations appropriations bill (H.R. 3362) to create funding limitation on organizations that promote or perform abortion and organizations that participate in coercive abortion programs. Contacts in support of retaining the adoption tax credit (section 1102(b)) as well as the exclusion for adoption assistance programs (section 1406) in H.R. 1, the Tax Cuts and Jobs Act of 2017. Contacts in support of the Daines Amendment, not introduced, to extend the child tax credit to cover unborn children to H.R. 1, the Tax Cuts and Jobs Act of 2017. Contacts in support of legislation, not introduced, to extend the child tax credit to cover unborn children. Contacts in regards to the Aderholt Amendment to the FY 2018 Financial Services appropriations bill (H.R. 3280) related to ICE detainees and access to abortion services. Contacts in support of including the enactment of the Conscience Protection Act and "Hyde Amendment" protections on any funds that may be appropriated to stabilize Obamacare healthcare markets in FY18 spending legislation. Contacts in support of "Hyde Amendment" protections to prevent allowing funds to flow to health plans that cover elective abortions to the Further Additional Continuing Appropriations Act, 2018, to provide continuing FY2018 appropriations to most federal agencies through January 19, 2018.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2017 · third_quarter · Q3
Contacts in support of laws to protect unborn children within the Federal District, including contacts in support of preservation of the "D.C. Hyde Amendment," a prohibition on the use of any congressionally appropriated funds (however labeled by local officials) for abortions (with certain exceptions) in the District of Columbia, in any FY 2017 continuing resolution and in any appropriations vehicle for FY 2018. Contacts in opposition to all ongoing efforts to evade constitutionally required congressional control over spending by the local administrative government of the Federal District, including District Council initiative to institute illegal expenditures of funds without congressional appropriation, in violation of the federal Anti-Deficiency Act and the Home Rule Act. Contacts in support of language in omnibus appropriations bill (H.R. 3354) to nullify local "budget autonomy" enactment, and in opposition to Norton Amendment to remove this provision (the House rejected the Norton Amendment, Sept. 14, 2017, and passed H.R. 3354). Contacts in support of Palmer Amendment to omnibus appropriations bill (H.R. 3354), to prohibit local government from expending funds to enforce Reproductive Health Nondiscrimination Act (RHNDA); House adopted Palmer Amendment, Sept. 14, 2017, and passed H.R. 3354). Contacts in support of Harris Amendment to the FY 2018 Financial Services appropriations bill (unnumbered) to overturn the District of Columbia local law regarding physician-assisted suicide; adopted in House Appropriations Committee on July 13, 2017.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2017 · second_quarter · Q2
Contacts in opposition to H.J. Res. 33, S.J.Res.6, proposing to add certain language termed an "Equal Rights Amendment" to the U.S. Constitution, unless an "abortion-neutral amendment" is added. Contacts in opposition to H.J.Res 53, S.J.Res 5, resolutions embracing the erroneous concept that the long-dead 1972 "Equal Rights Amendment" can still be ratified by new states if Congress passes ex post facto legislation declaring inoperative the ratification deadline contained in the 1972 resolution.
Contacts in support of laws to protect unborn children within the Federal District, including contacts in support of preservation of the "D.C. Hyde Amendment," a prohibition on the use of any congressionally appropriated funds (however labeled by local officials) for abortions (with certain exceptions) in the District of Columbia, in any FY 2017 continuing resolution and in any appropriations vehicle for FY 2018. Contacts in opposition to all ongoing efforts to evade constitutionally required congressional control over spending by the local administrative government of the Federal District, including District Council initiative to institute illegal expenditures of funds without congressional appropriation, in violation of the federal Anti-Deficiency Act and the Home Rule Act. Contacts in support of Harris Amendment to the FY 2018 Financial Services appropriations bill (unnumbered) to overturn the District of Columbia local law regarding physician-assisted suicide; adopted in House Appropriations Committee on July 13, 2017.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2017 · first_quarter · Q1
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page.
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page.
Contacts in support of inclusion in budget reconciliation legislation of provisions to (1) repeal and replace provisions of Public Law 111-148 ("Obamacare") that contain multiple abortion-subsidizing and abortion-expanding aspects; (2) incorporate certain tax provisions that facilitate coverage for lifesaving care in private health plans; and (3) deny most federal funding for the Planned Parenthood Federation of America, the nation's largest abortion provider, and its affiliates; this became H.R.1628, the American Health Care Act (supported, including letter to House dated March 17, 2017). Contacts in support of retention of all current pro-life limitation amendments and other pro-life provisions on continuing resolution or other appropriations vehicle for balance of FY 2017, and for FY 2018 appropriations.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2016 · fourth_quarter · Q4
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Contacts in support of repealing the Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would 1) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny lifesaving medical treatment, 2) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing "quality and efficiency" measures on health care providers, limiting the circumstances in which treatments can be given to their patients, and 4) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an "excessive or unjustified" amount on their own health care, thereby restricting the medical treatment. Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments. Contacts regarding S. 1549, the Care Planning Act of 2015 because 1) it fails to contain proper safeguards against dissuading patients to reject life-saving treatment they would otherwise want both to cut costs, and also due to a pervasive quality of life ethic 2) it authorizes health care providers to deny life-preserving treatment against the express will of a patient or surrogate invalidating several state protective laws and 3) advance planning documents that may have been filled out in other states are to be implemented removing state power over informed consent requirements surrounding choosing life-saving measures, food and fluids. Contacts in the U.S. Senate in support of S.2297, the Medicare Choices Empowerment and Protection Act, which would give Medicare beneficiaries and others online access to a website with state-specific model advance directives that choose life-saving treatment, food and fluids equally with those that reject them. Contacts in the U.S. House in support of H.R. 4059, the Medicare Choices Empowerment and Protection Act, which would give Medicare beneficiaries and others online access to a website with state-specific model advance directives that choose life-saving treatment, food and fluids equally with those that reject them. Contacts regarding advance care planning legislation (not introduced) 1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, 2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, 3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act 4) include oversight for grant approval for physician orders for lifesustaining treatment and 5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding legislation (not introduced) regarding the Patient Protection and Affordable Care Act, Public Law 111-148, provision related to the excise tax on employer-paid health insurance premiums above a governmentally imposed limit that does not allow for medical inflation because the excess benefits tax will have its intended result of effectively imposing a price control on health insurance premiums. Contacts in the U.S. House in support of H.R. 3251 which would prohibit the coverage of advance care planning services under the Medicare Program because unmonitored advance care planning services can in practice be used to nudge patients to agree to forego life-saving treatment and even assisted feeding through the use of unbalanced, distorted, and even inaccurate information. Contacts regarding H.R. 3119, the "Palliative Care and Hospice Education and Training Act" as to whether provisions of the Assisted Suicide Funding Restriction Act would be revoked. Contacts regarding legislation (not introduced) regarding potential legislation related to strengthening Federal policy against physician assisted suicide. Contacts regarding legislation (not introduced) regarding potential legislation related to the actions of the D.C. council pertaining to the "Death with Dignity Act" (B21-0038) and associated violations of the Assisted Suicide Funding Restriction Act of 1997, Pub. L. No. 105-12. National Right to Life opposes the "Death with Dignity Act" and favors congressional nullification thereof. Contacts in the U.S. House regarding potential CMS action in regards to the advance care planning services that have been added to the list of services in the Physician Fee Schedule payment rule.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2016 · third_quarter · Q3
Contacts in support of repealing the Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would 1) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 2) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment, and 5) eliminate the provisions related to shared decisionmaking because they are likely to be used, on balance, to dissuade patients from choosing life-saving treatment. Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments. Contacts regarding S. 1549, the Care Planning Act of 2015 because 1) it fails to contain proper safeguards against dissuading patients to reject life-saving treatment they would otherwise want both to cut costs, and also due to a pervasive quality of life ethic 2) it authorizes health care providers to deny life-preserving treatment against the express will of a patient or surrogate invalidating several state protective laws and 3) advance planning documents that may have been filled out in other states are to be implemented removing state power over informed consent requirements surrounding choosing life-saving measures, food and fluids. Contacts in the U.S. Senate in support of S.2297, the Medicare Choices Empowerment and Protection Act, which would give Medicare beneficiaries and others online access to a website with state-specific model advance directives that choose life-saving treatment, food and fluids equally with those that reject them. Contacts in the U.S. House in support of H.R. 4059, the Medicare Choices Empowerment and Protection Act, which would give Medicare beneficiaries and others online access to a website with state-specific model advance directives that choose life-saving treatment, food and fluids equally with those that reject them. Contacts regarding advance care planning legislation (not introduced) 1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, 2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, 3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act 4) include oversight for grant approval for physician orders for life-sustaining treatment and 5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding legislation (not introduced) regarding the Patient Protection and Affordable Care Act, Public Law 111-148, provision related to the excise tax on employer-paid health insurance premiums above a governmentally-imposed limit that does not allow for medical inflation because the excess benefits tax will have its intended result of effectively imposing a price control on health insurance premiums. Contacts in the U.S. House in support of H.R. 3251 which would prohibit the coverage of advance care planning services under the Medicare Program because unmonitored advance care planning services can in practice be used to nudge patients to agree to forego life-saving treatment and even assisted feeding through the use of unbalanced, distorted, and even inaccurate information. Contacts regarding H.R. 3119, the "Palliative Care and Hospice Education and Training Act" as to whether provisions of the Assisted Suicide Funding Restriction Act would be revoked. Contacts regarding legislation (not introduced) regarding potential legislation related to strengthening Federal policy against physician assisted suicide. Contacts in the U.S. House regarding potential CMS action in regards to the advance care planning services that have been recently added to the list of services in the Physician Fee Schedule payment rule.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2016 · second_quarter · Q2
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Contacts in support of repealing the Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would 1) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 2) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 5) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an "excessive or unjustified" amount on their own health care, thereby restricting the medical treatment, and 6) eliminate the provisions related to "shared decisionmaking" because they are likely to be used, on balance, to dissuade patients from choosing life-saving treatment. Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments. Contacts regarding S. 1549, the Care Planning Act of 2015 because 1) it fails to contain proper safeguards against dissuading patients to reject life-saving treatment they would otherwise want both to cut costs, and also due to a pervasive quality of life ethic 2) it authorizes health care providers to deny life-preserving treatment against the express will of a patient or surrogate invalidating several state protective laws and 3) advance planning documents that may have been filled out in other states are to be implemented removing state power over informed consent requirements surrounding choosing life-saving measures, food and fluids. Contacts in the U.S. Senate in support of S.2297, the Medicare Choices Empowerment and Protection Act, which would Give Medicare beneficiaries and others online access to a website with state-specific model advance directives that choose life-saving treatment, food and fluids equally with those that reject them. Contacts in the U.S. House in support of H.R. 4059, the Medicare Choices Empowerment and Protection Act, which would Give Medicare beneficiaries and others online access to a website with state-specific model advance directives that choose life-saving treatment, food and fluids equally with those that reject them. Contacts regarding advance care planning legislation (not introduced) 1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, 2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, 3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act 4) include oversight for grant approval for physician orders for life-sustaining treatment and 5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding legislation (not introduced) regarding the Patient Protection and Affordable Care Act, Public Law 111-148, provision related to the excise tax on employer-paid health insurance premiums above a governmentally imposed limit that does not allow for medical inflation because the excess benefits tax will have its intended result of effectively imposing a price control on health insurance premiums. Contacts in the U.S. House in support of H.R. 3251 which would prohibit the coverage of advance care planning services under the Medicare Program because unmonitored advance care planning services can in practice be used to nudge patients to agree to forego life-saving treatment and even assisted feeding through the use of unbalanced, distorted, and even inaccurate information. Contacts regarding H.R. 3119, the "Palliative Care and Hospice Education and Training Act" as to whether provisions of the Assisted Suicide Funding Restriction Act would be revoked.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2016 · first_quarter · Q1
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Contacts in support of repealing the Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would 1) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 2) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 5) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment, and 6) eliminate the provisions related to shared decisionmaking because they are likely to be used, on balance, to dissuade patients from choosing life-saving treatment. Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments. Contacts regarding S. 1549, the Care Planning Act of 2015 because 1) it fails to contain proper safeguards against dissuading patients to reject life-saving treatment they would otherwise want both to cut costs, and also due to a pervasive quality of life ethic 2) it authorizes health care providers to deny life-preserving treatment against the express will of a patient or surrogate invalidating several state protective laws and 3) advance planning documents that may have been filled out in other states are to be implemented removing state power over informed consent requirements surrounding choosing life-saving measures, food and fluids. Contacts in the U.S. Senate in support of S.2297, the Medicare Choices Empowerment and Protection Act, which would Give Medicare beneficiaries and others online access to a website with state-specific model advance directives that choose life-saving treatment, food and fluids equally with those that reject them. Contacts in the U.S. House in support of H.R. 4059, the Medicare Choices Empowerment and Protection Act, which would give Medicare beneficiaries and others online access to a website with state-specific model advance directives that choose life-saving treatment, food and fluids equally with those that reject them. Contacts regarding advance care planning legislation (not introduced) 1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, 2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, 3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act 4) include oversight for grant approval for physician orders for life-sustaining treatment and 5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding legislation (not introduced) regarding the Patient Protection and Affordable Care Act, Public Law 111-148, provision related to the excise tax on employer-paid health insurance premiums above a governmentally imposed limit that does not allow for medical inflation because the excess benefits tax will have its intended result of effectively imposing a price control on health insurance premiums. Contacts in the U.S. House in support of H.R. 3251 which would prohibit the coverage of advance care planning services under the Medicare Program because unmonitored advance care planning services can in practice be used to nudge patients to agree to forego life-saving treatment and even assisted feeding through the use of unbalanced, distorted, and even inaccurate information. Contacts regarding H.R. 3119, the "Palliative Care and Hospice Education and Training Act" as to whether provisions of the Assisted Suicide Funding Restriction Act would be revoked.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2015 · fourth_quarter · Q4
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Contacts in support of repealing the Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would 1) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 2) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 5) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment, and 6) eliminate the provisions related to shared decisionmaking because they are likely to be used, on balance, to dissuade patients from choosing life-saving treatment. Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments. Contacts regarding S. 1549, the Care Planning Act of 2015 because 1)it fails to contain proper safeguards against dissuading patients to reject life-saving treatment they would otherwise want both to cut costs, and also due to a pervasive quality of life ethic 2) it authorizes health care providers to deny life-preserving treatment against the express will of a patient or surrogate invalidating several state protective laws and 3) advance planning documents that may have been filled out in other states are to be implemented removing state power over informed consent requirements surrounding choosing life-saving measures, food and fluids. Contacts in the U.S. Senate in support of S.2297, the Medicare Choices Empowerment and Protection Act, which would Give Medicare beneficiaries and others online access to a website with state-specific model advance directives that choose life-saving treatment, food and fluids equally with those that reject them. Contacts in the U.S. House in support of H.R. 4059, the Medicare Choices Empowerment and Protection Act, which would Give Medicare beneficiaries and others online access to a website with state-specific model advance directives that choose life-saving treatment, food and fluids equally with those that reject them. Contacts regarding advance care planning legislation (not introduced) 1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, 2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, 3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act 4) include oversight for grant approval for physician orders for life-sustaining treatment and 5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding legislation (not introduced) regarding the Patient Protection and Affordable Care Act, Public Law 111-148, provision related to the excise tax on employer-paid health insurance premiums above a governmentally-imposed limit that does not allow for medical inflation because the excess benefits tax will have its intended result of effectively imposing a price control on health insurance premiums. Contacts in the U.S. House in support of H.R. 3251 which would prohibit the coverage of advance care planning services under the Medicare Program because unmonitored advance care planning services can in practice be used to nudge patients to agree to forego life-saving treatment and even assisted feeding through the use of unbalanced, distorted, and even inaccurate information.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2015 · third_quarter · Q3
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Contacts in support of repealing the Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would 1) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 2) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 5) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment, and 6) eliminate the provisions related to shared decisionmaking because they are likely to be used, on balance, to dissuade patients from choosing life-saving treatment. Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments. Contacts regarding S. 1549, the Care Planning Act of 2015 because 1)it fails to contain proper safeguards against dissuading patients to reject life-saving treatment they would otherwise want both to cut costs, and also due to a pervasive quality of life ethic 2) it authorizes health care providers to deny life-preserving treatment against the express will of a patient or surrogate invalidating several state protective laws and 3) advance planning documents that may have been filled out in other states are to be implemented removing state power over informed consent requirements surrounding choosing life-saving measures, food and fluids. Contacts regarding advance care planning legislation (not introduced) 1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, 2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, 3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act 4) include oversight for grant approval for physician orders for life-sustaining treatment and 5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding legislation (not introduced) regarding the Patient Protection and Affordable Care Act, Public Law 111-148, provision related to the excise tax on employer-paid health insurance premiums above a governmentally imposed limit that does not allow for medical inflation because the excess benefits tax will have its intended result of effectively imposing a price control on health insurance premiums. Contacts in the U.S. House in support of H.R. 3251 which would prohibit the coverage of advance care planning services under the Medicare Program because unmonitored advance care planning services can in practice be used to nudge patients to agree to forego life-saving treatment and even assisted feeding through the use of unbalanced, distorted, and even inaccurate information.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2015 · second_quarter · Q2
See abortion-related policy issues as reported under FAM (Family Issues/Abortion/Adoption). In addition: Contacts in support of repealing the Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would 1) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 2) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 5) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment, and 6) eliminate the provisions related to shared decisionmaking because they are likely to be used, on balance, to dissuade patients from choosing life-saving treatment. Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments. Contacts in regard to potential health reform legislation (not introduced) over concerns related to 1) the authority of any sort of health care commissions ability to restrict access to life-saving care, 2) premium price controls that might reduce the ability of insurance to cover life-saving care, 3) tax increases on health care or health insurance that create incentives for employers to significantly reduce health insurance plans, 4) efforts to prevent private health care spending from keeping up with medical inflation, and 5) malpractice limits being made applicable to intentional denial of treatment for discriminatory reasons. Contacts regarding S. 1549, the Care Planning Act of 2015 because 1) it fails to contain proper safeguards against dissuading patients to reject life-saving treatment they would otherwise want both to cut costs, and also due to a pervasive quality of life ethic 2) it authorizes health care providers to deny life-preserving treatment against the express will of a patient or surrogate invalidating several state protective laws and 3) advance planning documents that may have been filled out in other states are to be implemented removing state power over informed consent requirements surrounding choosing life-saving measures, food and fluids. Contacts regarding advance care planning legislation (not introduced) 1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, 2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, 3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act 4) include oversight for grant approval for physician orders for life-sustaining treatment and 5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding legislation (not introduced) in the U.S. House and Senate regarding the Patient Protection and Affordable Care Act, Public Law 111-148, provision related to the excise tax on employer-paid health insurance premiums above a governmentally-imposed limit that does not allow for medical inflation because the excess benefits tax will have its intended result of effectively imposing a price control on health insurance premiums. Contacts in support of legislation (not introduced) in the U.S. Senate because it would 1) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 2) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 5) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2015 · first_quarter · Q1
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
See abortion-related policy issues as reported under FAM (Family Issues/Abortion/Adoption). In addition: Contacts in support of repealing the Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would 1) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 2) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 5) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment, and 6) eliminate the provisions related to shared decisionmaking because they are likely to be used, on balance, to dissuade patients from choosing life-saving treatment. Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments. Contacts regarding legislation, not introduced to 1) ensure advance care planning legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, 2) ensure that there are not unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, and 3) ensuring that there are not adverse changes to the Assisted Suicide Funding and Restriction Act. Contacts in regard to potential health reform legislation (not introduced) over concerns related to 1) the authority of any sort of health care commissions ability to restrict access to life-saving care, 2) premium price controls that might reduce the ability of insurance to cover life-saving care, 3) tax increases on health care or health insurance that create incentives for employers to significantly reduce health insurance plans, 4) efforts to prevent private health care spending from keeping up with medical inflation, and 5) malpractice limits being made applicable to intentional denial of treatment for discriminatory reasons. Contacts regarding legislation (not introduced) regarding advance planning to ensure process of explaining, discussing, completing, or assisting in completing an advance directive is not used to dissuade patients from choosing life-saving treatment, nutrition and hydration. Contacts in support of legislation (not introduced) in the U.S. Senate because it would 1) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 2) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 5) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment. Contacts regarding H.R.1559 Health Outcomes, Planning, and Education (HOPE) for Alzheimer's Act of 2015 to indicate that it was unobjectionable.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2014 · fourth_quarter · Q4
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2014 · third_quarter · Q3
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2014 · second_quarter · Q2
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2014 · first_quarter · Q1
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2013 · fourth_quarter · Q4
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2013 · third_quarter · Q3
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2013 · second_quarter · Q2
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2013 · first_quarter · Q1
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2013 · first_quarter · Q1
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2012 · fourth_quarter · Q4
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2012 · third_quarter · Q3
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2012 · second_quarter · Q2
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2012 · first_quarter · Q1
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2011 · fourth_quarter · Q4
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care ratioining are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2011 · second_quarter · 2A
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care ratioining are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2011 · third_quarter · Q3
Contacts in support of No Taxpayer Funding for Abortion Act, S. 906 / H.R. 3. Contacts in support of H.R. 361/S. 165 (Abortion Non-Discrimination Act) and inclusion of this language in the FY 2012 appropriations legislation for DHHS. Contacts in support of legislative proposals to block or reduce federal funds for the Planned Parenthood Federation of America (PPFA), the nation's largest abortion provider. Consultations regarding inclusion of language (continued) in FY 2012 appropriations bill(s) to curb subsidies for abortion under the Patient Protection and Affordable Care Act (PL 111-148). Contacts in support of S. 314 (Unborn Child Pain Awareness Act) and potential additional legislation to protect pain-capable unborn children. Contacts in support of Child Interstate Abortion Notification Act (S. 1241, H.R. 2299). Consultations regarding drafting of "Heartbeat Informed Consent Act," introduced October 6, 2011, as H.R. 3130. Letter to House in support of Heartbeat Informed Consent Act, September 28, 2011. Contacts in opposition to H.R. 2543, legislation to invite federal harassment of pregnancy resource centers. Contacts in support of retention of all pro-life limitations provisions in first FY 2012 continuing resolution, H.R. 2017 (enacted September 30, 2011, PL 112-33), and in regular FY 2012 appropriations bills, including Labor-HHS-Education appropriations bill (H.R. 3070, S. 1599). Contacts in support of retention of pro-life limitation provisions of Commerce, Justice, State appropriations bill for FY 2012 (H.R. 2596, S. 1572). Contacts in support of retention of "D.C. Hyde Amendment" and prohibition on abortion coverage in FEHB program in FY 2012 Financial Services appropriations bill (H.R. 2434, S. 1573).
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2011 · second_quarter · Q2
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care ratioining are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2010 · fourth_quarter · Q4
Contacts in support of legislation (not introduced) to repeal or revise certain components of Public Law 111-148 regarding the Independent Payment Advisory Boards authority to make recommendations, both in regards to government funded and private insurance, to slow the growth in national health expenditures below the rate of medical inflation. (continued) Oppose the authority of the Secretary of Health and Human Services or other Federal agencies to impose quality and efficiency measures that may be designed to limit what people spend in health care. Contacts in support of legislation (not introduced) to repeal or revise certain components of Public Law 111-148 regarding the authority of CMS to refuse to allow Medicare participants the choice of private-fee-for-service plans, which allow seniors to voluntarily add their own funds on top of the government contribution to obtain a plan less likely to deny care. Contacts in support of legislation (not introduced) to repeal or revise certain components of Public Law 111-148 regarding the authority of state health insurance exchanges administrators to limit premiums and plan values that insurers may offer inside and outside of the exchange should the insurer participate, having the effect of limiting what can be charged for health insurance, therefore restricting what people are allowed to pay for medical treatment. Contacts in support of legislation (not introduced) to repeal or revise certain components of Public Law 111-148 regarding shared decisionmaking due to lack of oversight, lack of balance in the materials and decision aids, and lack of safeguards in the creation of disseminating organization, which may lead to discouraging patients from seeking treatment. Contacts in response to inquiries regarding implementation of certain elements of Public Law 111-148 related to the denial of life-saving medical treatments. Contacts in response to inquiries regarding Medicare regulation, CMS-2010-0205-1983, which would provide for end-of-life counseling during annual visits. U.S. House of Representatives only: Contacts in regards to H.R. 4529 (111th Cong.), Roadmap for Americas Future Act, regarding concerns over authority of a Health Care Services Commissions ability to restrict access to life-saving care; regarding concerns over premium price controls that might reduce the ability of insurance to cover expensive life-saving care; and regarding malpractice limits being made applicable to intentional denial of treatment, denied for discriminatory reasons.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2010 · third_quarter · Q3
Contacts in support of legislation (not introduced) to repeal or revise certain components of Public Law 111-148 to prevent the Independent Payment Advisory Board from recommending, and the Secretary of Health and Human Services from implementing, standards specifically designed to limit both governmental and private insurance health care spending so that it is below the rate of medical inflation which will lead to denial of life-saving medical treatments. (continued) Contacts in response to inquiries regarding implementation of certain elements of Public Law 111-148 related to the denial of life-saving medical treatments. (Senate only:) Contacts in opposition to the confirmation of Donald Berwick as the Director of Center for Medicare and Medicaid Services due to his views favoring strong government limits on the implementation of life-saving medical technology, support of price caps, and the expressed view that some individuals ought to be prevented from being able to obtain better health care than others.
Contacts in support of legislation (not introduced) to repeal or revise certain components of Public Law 111-148 to prevent the Independent Payment Advisory Board from recommending, and the Secretary of Health and Human Services from implementing, standards specifically designed to limit both governmental and private insurance health care spending so that it is below the rate of medical inflation which will lead to denial of life-saving medical treatments. (continued) Contacts in response to inquiries regarding implementation of certain elements of Public Law 111-148 related to the denial of life-saving medical treatments.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2010 · second_quarter · Q2
Same issues as reported on HCR pages.
U.S. HOUSE OF REPRESENTATIVES: Contacts regarding H.R.3590, the Patient Protection and Affordable Care Act disincentives for balanced counseling and incentives to steer them toward rejection of treatment, including life-preserving treatment, which lacks representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life, and which lacks continuing oversight. (continued) SENATE AND HOUSE OF REPRESENTATIVES: Opposition to the confirmation of Donald Berwick as the Director of Center for Medicare and Medicaid Services due to his views favoring strong government limits on the implementation of lifesaving medical technology, support of price caps, and the expressed view that some individuals ought to be prevented from being able to obtain better health care than others.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2010 · first_quarter · Q1
Contacts in support of amendments to remove pro-abortion mandates and abortion subsidies from health care reform bills. (continued) Opposed "Patient Protection and Affordable Care Act" (H.R. 3590), as passed by the Senate on December 24, 2009. In the House, advocated multiple revisions to correct pro-abortion provisions, including addition of language similar to the Stupak-Pitts Amendment added by the House to H.R. 3962 on November 7, 2009), to correct provisions that would otherwise allow or require funding of abortion, subsidies for health plans that cover abortion, and/or pro-abortion administrative mandates, such as language found in H. Con. Res. 254. Also contacts in support of the addition of "Hyde-Weldon" provision from H.R. 3962 (Section 259) to H.R. 3590. Contacts to House and Senate offices to explain that revisions proposed on February 22, 2010, by President Obama, would correct none of the abortion-related problems and make some worse. Contacts to House members pointing out that that no executive order could correct the objectionable provisions of the bill. Opposed concurrence in the Senate-passed bill (approved 219-212, March 21, 2010); signed into law March 23, 2010. Provided analysis of revisions needed to H.R. 4529, Roadmap for America's Future Act, to prevent pro-abortion effects. (continued) U.S. Senate Contacts in effort to oppose measures that could enable the rationing of health care, supported the addition of variable withhold financing method to avoid rationing. Contacts in opposition to the Senate provisions wherein Commissioners of the State Health Insurance Exchanges are given discretion to impose price controls on insurance premiums under Section 1003 thus limiting access to plans able to provide unrationed care. Contacts in opposition to H.B. 3962s section 3209s grant of discretion to CMS to deny older Americans the choice of plans whose premiums CMS deems too high thus limiting access to plans able to provide unrationed care. Contacts in opposition to the inclusion of concepts from the February 22, 2010 Obama Administration health care proposal which would have imposed premium price controls on private plan and denied senior citizens their current right to add their own money on top of the government Medicare contribution to get health insurance less likely to deny treatment through tightly controlled managed care. U.S. House of Representatives Contacts in effort to oppose measures that could enable the rationing of health care, supported the addition of variable withhold financing method to avoid rationing. Contacts in opposition to the Senate provisions wherein Commissioners of the State Health Insurance Exchanges are given discretion to impose price controls on insurance premiums under Section 1003 thus limiting access to plans able to provide unrationed care. Contacts in opposition to H.B. 3962s section 3209s grant of discretion to CMS to deny older Americans the choice of plans whose premiums CMS deems too high thus limiting access to plans able to provide unrationed care. Contacts in opposition to the inclusion of concepts from the February 22, 2010 Obama Administration health care proposal which would have imposed premium price controls on private plan and denied senior citizens their current right to add their own money on top of the government Medicare contribution to get health insurance less likely to deny treatment through tightly controlled managed care. Contacts expressing general concerns about denial of treatment and rationing provisions in H.R. 4529, the "Roadmap for America's Future Act" including the inconsistency in rejection of premium price controls and the clarification that malpractice reform limitations ought not to apply to intentional discriminatory denial of life-preserving treatment.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2009 · fourth_quarter · Q4
U.S. Senate: On the Senate Finance Committees Bill, Americas Healthy Future Act of 2009, contacts in support of addition of variable withhold financing method to avoid rationing. (continued) Contacts in support of the anti-discrimination language as it related to Comparative Effectiveness Research. Contacts in support of extending the comparative effectiveness anti-discrimination language to other places of the mark where the Secretary is given authority to determine quality. Contacts in support of Sen. Kyl amendment D2-125. Contacts to oppose Rockefeller amendments 207, 208, and 210, relating to advance care planning because: contains disincentive for balanced counseling and incentives to steer them toward rejection of treatment, including life-preserving treatment, lacks representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life, lacks continuing oversight and evaluation of created board, lacks protections for portability of advanced directives across states, lacked conscience protections, and made changes to Assisted Suicide Funding Restriction Act of 1997. Contacts in support of conscience protection that does not extend to protecting providers against denial of medical care to an individual because of the individuals age, disability, or other characteristic. On the process of merging S.1679, the Affordable Health Choices Act, with the Senate Finance Committees Bill, Americas Healthy Future Act of 2009, contacts in support of elimination of 5% penalty for top 10% of Medicare outliers. Contacts in opposition to the inclusion of Advance Care planning which contains disincentive for balanced counseling and incentives to steer them toward rejection of treatment, including life-preserving treatment, lacks representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life, and lacks continuing oversight. Contacts in opposition to inclusion of language which would preclude providers from providing or prescribing any treatment or diagnostic procedure. Contacts to ensure that taxpayer funds do not support or fund physician assisted suicide. Contacts in support of extending the comparative effectiveness anti-discrimination language to other places of the mark where the Secretary is given authority to determine quality. On "Patient Protection and Affordable Care Act" (substitute amendment to H.R. 3590), contacts in opposition to Senator Rockefeller, Lieberman, and Whitehouse Amendment 3240 which would empower the Independent Medicare Advisory Board to recommend, and the Secretary of Health and Human Services to impose, requirements for insurance plans in the exchanges that would have the effect of limiting Americans right to spend their own money, if they choose, to save their own lives. Contacts in opposition to Shared Decisionmaking, Section 3506, due to lack of safeguards against pressure to reject costly life-saving treatment. Opposed cloture due to: 1)The Independent Payment Advisory Boards authority to make cuts in Medicare and charge to make recommendations to limit non-federal health expenditures thus limiting access to plans able to provide unrationed care. 2) The Commissioners of the State Health Insurance Exchanges discretion to impose price controls on insurance premiums under Section 1003 thus limiting access to plans able to provide unrationed care. 3) Section 3209 grant of discretion to CMS to deny older Americans the choice of plans whose premiums CMS deems too high thus limiting access to plans able to provide unrationed care. 4) Multiple provisions in the bill which could be used to establish quality and efficiency standards that would result in the denial of lifesaving medical care based upon degree of disability, age, or quality of life. On health care reform generally, contacts in effort to oppose rationing of health care, supported the addition of variable withhold financing method to avoid rationing. U.S. House of Representatives: On H.R. 3962, America's Affordable Health Choices Act of 2009, contacts in support of language to exclude rationing of health care. Contacts in opposition to the Commissioners of the Health Insurance Exchanges discretion to impose price controls on insurance premiums, exclude fee-for-service plans, or require plans to deny policyholders life-saving medical treatment. Contacts in opposition to the grant of discretion to CMS to deny those in Medicare the choice of plans whose premiums CMS deems too high, or by imposing Section 1165s local requirements, thus limiting access to plans able to provide unrationed care. Contacts to support language that would ensure that neither the Exchange or the public insurance option employ a pattern or practice of discrimination based on the age, disability or purported "quality of life" of the patient. Contacts in opposition to Section 2401 which creates a Center for Quality Improvement which is to promote best practices in health care where quality-adjusted life year measures or any other methodologies that can be used to deny benefits to a beneficiary against the beneficiarys wishes on the basis of the beneficiarys age, life expectancy, present or predicted disability, or expected quality of life may be used in several of its duties. Contacts in opposition to Section 1401, which creates a Center for Comparative Effectiveness Research (continued) and 1159's provisions commissioning the Institute of Medicine to develop new Medicare reimbursement standards to create incentives for high value care which do not protect against discrimination based on age, life expectancy, present or predicted disability, or expected quality of life. Contacts in support of prohibition of using quality adjusted life years (or other standards that discount the value of a period of life based on the patients present or predicted disability or quality of life) being employed in making coverage decisions, determining reimbursement rates, or establishing incentive programs. Contacts in support of the inclusion of Comparative Effectiveness panel members that represent disability rights organizations as well as represent organizations that advocate for the rights of patients to obtain treatment without regard to the patients quality of life. Contacts in opposition to Section 1233 advance care planning provisions that could be used to encourage Medicare patients to accept the denial of treatment as a means of cost control, and despite apparent prohibitions, could include assisted suicide. Contacts in opposition to Section 240 which requires health insurers participating in the exchange to provide beneficiaries with the option to establish advance directives and disseminate imbalanced information about end-of-life planning. On health care reform generally, contacts in effort to oppose rationing of health care, supported the addition of variable withhold financing method to avoid rationing.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2009 · third_quarter · Q3
U.S. Senate On the Senate Finance Committees Chairmans Mark, Americas Healthy Future Act of 2009, contacts in support of addition of variable withhold financing method to avoid rationing. Contacts in support of the Chairmans mark anti-discrimination language as it related to Comparative Effectiveness Research. (continued) Contacts in support of extending the comparative effectiveness style anti-discrimination language to other portions of the mark. Contacts in support of Sen. Kyl amendment D2-125 and Sen. Roberts amendment D1-137 which would eliminate the 5% penalty for Medicare physicians in the top 10% of spending. Contacts in support of Kyl amendment 152 which would allow senior citizens to opt out of Medicare. Contacts to oppose Rockefeller amendments 207, 208, and 210, relating to advance care planning because: contains disincentive for balanced counseling and incentives to steer them toward rejection of treatment, including life-preserving treatment, lacks representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life, lacks continuing oversight and evaluation of created board, lacks protections for portability of advanced directives across states, lacked conscience protections, and made changes to Assisted Suicide Funding Restriction Act of 1997. Contacts to support Bunning Amendment D3-135 or Bunning Amendment D1-130 to require a Congressional vote in order to implement recommendations of the Medicare Commission. On S.1679, the Affordable Health Choices Act, contacts in support of the addition of variable withhold financing method to avoid rationing. Contacts in support of Enzi Amendment 210 to prohibit the community health insurance option from denying patients medical care needed to prevent their deaths or preserve or restore their health. Contacts in support of Enzi Amendment 271 to prohibit regulation that preclude plan or issuer from providing payment for a treatment or diagnostic procedure it chooses to cover, unless such treatment or procedure has been determined to be unsafe or dangerous. Contacts in support of Enzi Amendment 272 to prevent denial of care based on patient age, disability, medical dependency or quality of life. Contacts in support of Enzi Amendment 273 to prohibit regulations that preclude providers from providing or prescribing any treatment or diagnostic procedure that has not been determined to be unsafe or dangerous. Contacts in support of Enzi Amendment 274 to prohibit the Exchange from excluding qualified plans by: using premium price controls, excluding fee-for-service plans, or requiring plans to deny policyholders life-saving medical treatment. Contacts in support of Enzi Amendment 279 which would preserve the option of fee-for-service healthcare. Contacts in support of Enzi Amendment 280 which would prevent the denial of end of life care and which would prohibit the Exchange from excluding plans that choose not to limit access to therapies and treatment. Contacts in support of Enzi Amendment 283 which would prohibit the Secretary of Health and Human Services from setting payment rates for items and services that are medically necessary. Contacts in support of Enzi Amendment 284 which would prohibit the Secretary of Health and Human Services from limiting access to any therapies or treatments that are medically necessary. Contacts in support of Enzi Amendment 285 to prohibit the Secretary of Health and Human Services from limiting access to end of life care by allowing the public option to employ a pattern or practice of discrimination based on the age, disability or purported "quality of life" of the patient. Contacts regarding Sen. Hatch amendment 229 to ensure that taxpayer funds do not support or fund physician assisted suicide. Contacts regarding Sen. Coburn Amendment 237 that would ensure healthcare providers are not forced to participate in assisted suicide or discriminated against because they choose not to participate in assisted suicide. Contacts regarding Sen. Coburn amendment 220 for general conscience protection and protection against discrimination. On S. 1213, The Patient-Centered Outcomes Research Act of 2009, regarding comparative effectiveness standards in Medicare, worked to ensure that patients competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes. On S. 1133, Empowering Medicare Patient Choices Act, supported the removal of language which creates an unacceptable disincentive for balanced counseling and assistance that genuinely attempts to elucidate patients values and preferences, and an incentive to steer them toward rejection of treatment, including life-preserving treatment. Urged the inclusion on advisory council of representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life. On S.1263 Senior Navigation and Planning Act of 2009, supported the removal of language which creates an unacceptable disincentive for balanced counseling and assistance that genuinely attempts to elucidate patients values and preferences, and an incentive to steer them toward rejection of treatment, including life-preserving treatment. Urged the inclusion on advisory board of representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life. Urged continuing oversight and evaluation by created board. Urged changes to provisions regarding portability of advanced directives across states. Urged the inclusion of conscience protections. On Senate 1150 Advance Planning and Compassionate Care Act of 2009, urged that a qualified oversight body make recommendations concerning various informational elements of the legislation. Opposed provision that would repeal provisions of the Assisted Suicide Funding Restriction Act. Sought the inclusion of protective language that would safeguard state modifications when they had adopted the Uniformed Health Care Decisions Act. On health care reform generally, contacts in effort to oppose rationing of health care and support the addition of variable withhold financing method to avoid rationing. U.S. House of Representatives On H.R. 3200, America's Affordable Health Choices Act of 2009, contacts in support of language to exclude rationing of health care. Contacts in support of language to prevent comparative effectiveness research from being used in making coverage decisions, determining reimbursement rates, or establishing incentive programs in ways that discriminatorily deny or limit health care based on age, present or predicted disability, or expected length of life. Contacts in support of prohibition of using quality adjusted life years (or other standards that discount the value of a period of life based on the patients present or predicted disability or quality of life) being employed in making coverage decisions, determining reimbursement rates, or establishing incentive programs. Contacts in support of the inclusion of Comparative Effectiveness panel members that represent disability rights organizations as well as represent organizations that advocate for the rights of patients to obtain treatment without regard to the patients quality of life. Contacts in support of prohibiting Commissioner from terminating qualified plans by: using premium price controls, excluding fee-for-service plans, or requiring plans to deny policyholders life-saving medical treatment. Contacts in support of prohibiting the Commissioner from implementing premium price controls. Contacts to support striking a section that would incent Medicare providers to limit treatment utilization. Contacts to support language that would ensure that neither the Exchange or the public insurance option employ a pattern or practice of discrimination based on the age, disability or purported "quality of life" of the patient. Contacts to support language to ensure that health benefits established as essential not be subject to denial to patients against their wishes on the basis of patients' age or expected length of life or of patients' present or predicted disability, degree of medical dependency, or quality of life. Contacts to support language that no health plan or health insurance issuer shall be forced to deny patients medical care needed to prevent their deaths or preserve or restore their health and no plan or issuer shall be prohibited from providing a treatment or diagnostic procedure it chooses to cover, unless such treatment or procedure has been determined to be unsafe, dangerous, or capable neither of preventing the patient's death nor of preserving or restoring the patient's health. On health care reform generally, contacts in effort to oppose rationing of health care and support the addition of variable withhold financing method to avoid rationing. Executive Office of the President U.S. Senate Contacts in support of introduction of language into the Senate Finance Committees Chairmans Mark, Americas Healthy Future Act of 2009, to prevent comparative effectiveness research from being used in making coverage decisions, determining reimbursement rates, or establishing incentive programs in ways that discriminatorily deny or limit health care based on age, present or predicted disability, or expected length of life. Contacts in support of prohibition of using quality adjusted life years (or other standards that discount the value of a period of life based on the patients present or predicted disability or quality of life) being employed in making coverage decisions, determining reimbursement rates, or establishing incentive programs.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2009 · second_quarter · Q2
On Senator Max Baucuss Call to Action: Health Reform 2009 [commonly known as the Baucus White Paper on Health Reform], opposed rationing of health care, supported the addition of variable withhold financing method to avoid rationing. (continued) On the Senate Health Education Labor and Pensions Chairmans Mark titled, Affordable Health Choices Act, Opposed rationing of health care. Supported the addition of variable withhold financing method to avoid rationing. Urged that the secretary be precluded from rejecting plans based on: their having a fee-for service structure, or by imposing premium price controls, or by placing treatment limits. Urged against the incentivizing the denial of treatments deemed to be cost-ineffective on quality of life grounds. Urged against reimbursement methods which give broad authority to the Secretary to prohibit reimbursement to providers on safe treatments or procedures they wish to prescribe. Urged the support of Sen. Enzi amendments, 7 and 8, which would prohibit use of comparative effectiveness research to ration healthcare based on the governments assessment of whether elderly, disabled or medically dependent individuals merit treatment by preventing treatment denial. On potential Finance Committee Health Care legislation, opposed rationing of health care. Supported the addition of variable withhold financing method to avoid rationing. Urged that there be a prohibition of any standard that discounts the value of a period of life based on the patients present or predicted disability or quality of life. Urged that provisions be added to Comparative Effectiveness elements of any bill that would ensure that patients competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life not be used as the basis for denial of Medicare benefits to patients against their wishes. On the Healthy Americans Act (S. 391), opposed rationing of health care, supported the addition of variable withhold financing method to avoid rationing. Discussions generally on potential health care reform generally, opposed rationing of health care, supported the addition of variable withhold financing method to avoid rationing. On the tri-committee House draft, H. R. __, titled To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes, opposed rationing of health care. Supported the addition of variable withhold financing method to avoid rationing. Urged that the secretary be precluded from rejecting plans based on: their having a fee-for service structure, or by imposing premium price controls, or by placing treatment limits. Urged that there be a prohibition of any standard that discounts the value of a period of life based on the patients present or predicted disability or quality of life. Urged the removal of elements that incentivize denial of treatment. Urged against the incentivizing the denial of treatments deemed to be cost-ineffective on quality of life grounds. Urged against reimbursement methods which give broad authority to the Secretary to prohibit reimbursement to providers on safe treatments or procedures they wish to prescribe. Urged that provisions be added to Comparative Effectiveness elements of any bill that would ensure that patients competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life not be used as the basis for denial of Medicare benefits to patients against their wishes. Discussion generally on potential Comparative Effectiveness elements of health reform bills, regarding comparative effectiveness standards in Medicare, worked to ensure that patients competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes. On Senate 1213, The Patient-Centered Outcomes Research Act of 2009, regarding comparative effectiveness standards in Medicare, worked to ensure that patients competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes. On Senate 1133, Empowering Medicare Patient Choices Act, supported the removal of language which creates an disincentive for balanced counseling and assistance that genuinely attempts to elucidate patients values and preferences, and an incentive to steer them toward rejection of treatment, including life-preserving treatment. Urged for the inclusion of representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life. (continued) On Senate 1263 Senior Navigation and Planning Act of 2009, supported the removal of language which creates a disincentive for balanced counseling and assistance that genuinely attempts to elucidate patients values and preferences, and an incentive to steer them toward rejection of treatment, including life-preserving treatment. Urged for the inclusion of representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life. Urged for continuing oversight and evaluation of created board. Urged for changes to provisions regarding portability of advanced directives across states. Urged for the inclusion of conscience protections. On Senate 1150 Advance Planning and Compassionate Care Act of 2009, urged for a qualified oversight body to make recommendations concerning various informational elements of the legislation. Strongly opposed provisions that would repeal provisions of the Assisted Suicide Funding Restriction Act. Sought the inclusion of protective language that would safeguard state modifications when a state had adopted the Uniformed Health Care Decisions Act.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2009 · first_quarter · Q1
On Senator Max Baucus's "Call to Action: Health Reform 2009" [commonly known as the "Baucus White Paper on Health Reform"], Healthy Americans Act (S. 391), and health care reform generally, opposed rationing of health care, supported addition of variable withhold financing method to avoid rationing. (continued) On American Recovery and Reinvestment Act of 2009 (H.R. 1), answered inquiries to provide assurances we were not opposing the bill. Attempted to discourage the use of phrases in Title XXX - HEALTH INFORMATION TECHNOLOGY AND QUALITY, Sec. 3001: "inappropriate care", "reducing health disparities" in order to alleviate the potential for "quality of life" judgments. Discussions generally on potential "Comparative Effectiveness" legislation, regarding comparative effectiveness standards in Medicare, worked to ensure that patient's competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes. Discussions regarding a possible federal bill to create a national registry for advanced directives (no such legislation introduced).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2008 · fourth_quarter · Q4
On legislation to reauthorize "global AIDS" (PEPFAR) program, provided analysis of various provisions and contemplated amendments; did not oppose HR 5501 as passed by the House or as ultimately amended by the Senate. On Medicare Improvements for Patients and Providers Act of 2008 (H.R. 6331), Section 162, answered inquiries to provide assurance we were not opposing the bill. (continued) On Senator Max Baucus's "Call to Action[:] Health Reform 2009" [commonly known as "Baucus White Paper on Health Reform"], Healthy Americans Act (S. 334), and health care reform generally, opposed rationing of health care, supported addition of variable withhold financing method to avoid rationing, analysis of abortion mandates and revisions to avoid enactment of abortion mandates. On Comprehensive Effectiveness Research Act of 2008 (S. 3408), regarding comparative effectiveness standards in Medicare, worked to ensure that patient's competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes. Support for S. 1810, Prenatally and Postnatally Diagnosed Conditions Act.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2008 · third_quarter · Q3
On Medicare Improvements for Patients and Providers Act of 2008 (H.R. 6331), Section 162, answered inquiries to provide assurance we were not opposing the bill. On Healthy Americans Act (S. 334), opposed rationing of health care, supported addition of variable withhold financing method to avoid rationing, analysis of abortion mandates and revisions to avoid enactment of abortion mandates. (continued) On contemplated legislation regarding comparative effectiveness standards in Medicare, worked to ensure that patient's competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes. On potential legislation to require the government to negotiate the price of prescription drugs in Medicare, explained our opposition.
On legislation to reauthorize "global AIDS" (PEPFAR) program, provided analysis of various provisions and contemplated amendments; did not oppose HR 5501 as passed by the House or as ultimately amended by the Senate. On Medicare Improvements for Patients and Providers Act of 2008 (H.R. 6331), Section 162, answered inquiries to provide assurance we were not opposing the bill. (continued) On Healthy Americans Act (S. 334), opposed rationing of health care, supported addition of variable withhold financing method to avoid rationing, analysis of abortion mandates and revisions to avoid enactment of abortion mandates. On contemplated legislation regarding comparative effectiveness standards in Medicare, worked to ensure that patient's competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes. On potential legislation to require the government to negotiate the price of prescription drugs in Medicare, explained our opposition. Support for S. 1810, Prenatally and Postnatally Diagnosed Conditions Act. Provided analysis of H.R. 6357, medical records legislation; opposed possible Markey Amendment unless revised (but Markey Amendment was not offered at mark up), no position on bill as reported by Energy & Commerce Committee.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2008 · second_quarter · Q2
On Medicare Improvements for Patients and Providers Act of 2008 (S. 3101), opposed rationing of Medicare through curtailing the private fee-for-service option. We worked to modify Section 163s provision relating to quality reporting to make it feasible for private fee-for-service plans. (continued) On Medicare Improvements for Patients and Providers Act of 2008 (H.R. 6331), Section 162, answered inquiries to provide assurance we were not opposing the bill. On Healthy Americans Act (S. 334), opposed rationing of health care, supported addition of variable withhold financing method to avoid rationing, analysis of abortion mandates and revisions to avoid enactment of abortion mandates. On contemplated legislation regarding comparative effectiveness standards in Medicare, worked to ensure that patient's competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes. On potential legislation to require the government to negotiate the price of prescription drugs in Medicare, explained our opposition. On legislation to reauthorize "global AIDS" (PEPFAR) program, did not oppose HR 5501 as passed by the House on April 2, 2008, but opposed some provisions of S. 2731 as approved by the Senate Foreign Relations Committee and urged revisions to inhibit exploitation of the program by abortion-promoting groups.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2008 · first_quarter · Q1
On contemplated legislation restructuring Medicare Advantage, opposed rationing of Medicare through curtailing private fee-for-service option. On Healthy Americans Act (S. 334), opposed rationing of health care, supported addition of variable withhold financing method to avoid rationing, analysis of abortion mandates and possible revisions to avoid enactment of abortion mandates. Analysis of National Health Care Decisions Day (SJ Res. 29, HJ Res. 77). (continued) On legislation to reauthorize "global AIDS" (PEPFAR) program: In the House of Representatives, analysis and opposition to Lantos drafts of January 18 and January 31, 2008. Analysis and opposition to anticipated pro-abortion amendments to successor bill HR 5501 (Berman-Ros-Lehtinen); such amendments were not offered in the House. In the Senate, analysis and opposition on Biden draft legislation, opposition to Boxer Amendment to Biden draft (not offered), lobbying in support of inclusion of elements of House-passed bill into final Senate bill. Supported Prenatally and Postnatally Diagnosed Conditions Awareness Act (S. 1810). On legislation (HR 1424) to establish certain parity requirements for mental health treatment benefits, provided analysis regarding possible abortion-related implications (took no position on House passage of bill); subsequent contacts regarding treatment of abortion-related concerns in possible conference with narrower Senate-passed bill (S. 558).
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2007 · year_end · YY
Opposed possible pro-abortion amendments and supported possible pro-life amendments to defense authorization bill (HR 1585) (no such amendments were offered).
Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Supported ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2007 · mid_year · MA
Supported prohibition on funding of abortion by D.C. city government in HR 2829 (Financial Services Appropriations bill), and opposed HR 733, a bill that would nullify this limitation amendment, unless revised by adoption of Jordan Amendment to H.R. 733. Discussion of constitutional implications of HR 1433 and S. 1257 (granting voting status to non-State federal enclave).
legislation consistent with Supreme Court ruling in Gonzales v. Carhart. Supported HR 457 (to promote research into post-abortion depression, etc.), and supported proposal to add comparable provisions to HR 20. Supported HR 223 (Informed Choice Act), and advised re: formulation of additional ultrasound-related legislation. Supported HR 1063 (Child Interstate Abortion Notification Act), S. 356 and HR 3442 (Unborn Child Pain Awareness Act). Supported S. 350 (Abortion Non-Discrimination Act). Supported S. 351 (Title X reform). Supported veto and sustaining of veto of any bill that weakens any existing pro-life policy. Opposed S. 1173, HR 1964 ("Freedom of Choice Act"). Advised re: abortion-related (cont.)
NATIONAL RIGHT LIFE COMMITTEE via NATIONAL RIGHT TO LIFE COMMITTEE
2007 · mid_year · MM
Supported S. 561, HR 471 (Adoption Tax Relief Guarantee Act). Responded to inquiry re: tax deduction status of abortion.
Opposed proposals to place restrictions on communications to the public about events in Congress; supported Bennett Amendment to S. 1; opposed H.R. 2093 (Meeehan-Shays) and Meehan Amendment to H.R. 2316. Opposed proposals to amend H.R. 2316/S.1 to require reporting of donors/members. Opposed H.R. 984, "Executive Branch Reform Act," a proposal to require reporting into government database of communications from the public to political appointees. (continued) Supported Broadcaster Freedom Act (HR. 2905, S. 1742), and Pence Amendment to H.R. 2829, to prohibit enforcement of "Fairness Doctrine." Regarding Genetic Information Nondiscrimination Act (HR 493), supported revisions to prevent discrimination against unborn children and adoptive families. Supported HR 618. Responded to inquiries regarding HR 1094.
Contacts regarding PEPFAR reauthorization over whether federal funds are going to funding recipients who also promote abortion.
Contacts in opposition to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. These include: -- opposition to signing of House Discharge Petition No. 6 (Pressley), filed July 18, 2023, seeking discharge of H.J. Res. 25. -- opposition to S.J. Res. 39 (Gillibrand) and H.J. Res. 82 (Bush), expressing the non-binding "sense of Congress" that the Equal Rights Amendment has been ratified and that the Archivist "should" publish/certify it. -- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes by certain members of Congress and others to pressure the Archivist of the United States to certify the ERA in contravention of multiple federal court rulings. -- support for Senate Resolution 107 (Hyde-Smith), expressing the sense of the Senate that Congress lacks power to act on a constitutional amendment resolution after submitting it to the states, or to revive an expired amendment proposal.
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries. Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion. Contacts in support of legislation (not introduced) to require abortion numbers from the VA.
Contacts in support of proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation," 88 FR 12875 (March 1, 2023), (RIN): 1117-AB40, Docket ID DEA-407 due to impact of assisted suicide drugs. Contacts regarding vending machine dispensing of chemical abortion drugs.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability. Contacts in support of Simon's Law requiring providers to inform at least one parent or legal guardian of a physicians intent to institute a DNR both orally and in writing and providing either parent with authority to refuse consent for a DNR. Contacts in regards to legislation and resolutions on IVF, to the extend they might impact abortion policy. No position taken.
Contacts in opposition to proposed regulations, Regulations to Implement the Pregnant Workers Fairness Act, 88 Fed. Reg 54714 (August 11, 2023), (RIN): 3046-AB30) due to requirement that employers with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers. Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Filing targets: Drug Enforcement Administration (DEA), Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. These include: -- opposition to S.J. Res. 4 (Cardin) and H.J. Res. 25 (Pressley), resolutions purporting by multiple unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J. Res. 208 of the 92nd Congress, and to declare the long-expired 1972 Equal Rights Amendment to be part of the U.S. Constitution. (Cloture failed on motion to proceed to S. J. Res. 4, 51-47, on April 27, 2023.) -- opposition to signing of House Discharge Petition No. 6 (Pressley), filed July 18, 2023, seeking discharge of H.J. Res. 25. -- opposition to S.J. Res. 39 (Gillibrand) and H.J. Res. 82 (Bush), expressing the non-binding "sense of Congress" that the Equal Rights Amendment has been ratified and that the Archivist "should" publish/certify it. -- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes by certain members of Congress and others to pressure the Archivist of the United States to certify the ERA in contravention of multiple federal court rulings. -- support for Senate Resolution 107 (Hyde-Smith), expressing the sense of the Senate that Congress lacks power to act on a constitutional amendment resolution after submitting it to the states, or to revive an expired amendment proposal.
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries. Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY24 appropriations. Contacts in support of new riders including those related regulation of chemical abortion drugs, paying for elective health abortions at Veterans Affairs, and others related to defunding the Department of Defense policy to pay for abortion-related travel.
Contacts in opposition to proposed regulations, Regulations to Implement the Pregnant Workers Fairness Act, 88 Fed. Reg 54714 (August 11, 2023), (RIN): 3046-AB30) due to requirement that employers with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability. Contacts in support of Simon's Law requiring providers to inform at least one parent or legal guardian of a physicians intent to institute a DNR both orally and in writing and providing either parent with authority to refuse consent for a DNR.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of the Pregnant Students Rights Act, which would require institutions of higher education to disseminate information on the rights of, and accommodations and resources for, pregnant students. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria.
Contacts in support of proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation," 88 FR 12875 (March 1, 2023), (RIN): 1117-AB40, Docket ID DEA-407 due to impact of assisted suicide drugs. Contacts regarding vending machine dispensing of chemical abortion drugs.
Contacts regarding PEPFAR reauthorization over whether federal funds are going to funding recipients who also promote abortion.
Filing targets: Drug Enforcement Administration (DEA), Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Contacts regarding PEPFAR reauthorization over whether federal funds are going to funding recipients who also promote abortion.
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY24 appropriations. Contacts in support of new riders including those related regulation of chemical abortion drugs, paying for elective health abortions at Veterans Affairs, and others related to defunding the Department of Defense policy to pay for abortion-related travel.
Contacts in opposition to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability. Contacts in support of Simon's Law requiring providers to inform at least one parent or legal guardian of a physicians intent to institute a DNR both orally and in writing and providing either parent with authority to refuse consent for a DNR.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. These include: -- opposition to S.J. Res. 4 (Cardin) and H.J. Res. 25 (Pressley), resolutions purporting by multiple unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J. Res. 208 of the 92nd Congress, and to declare the long-expired 1972 Equal Rights Amendment to be part of the U.S. Constitution. (Cloture failed on motion to proceed to S. J. Res. 4, 51-47, on April 27, 2023.) -- opposition to signing of House Discharge Petition No. 6 (Pressley), filed July 18, 2023, seeking discharge of H.J. Res. 25. -- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes by certain members of Congress and others to pressure the Archivist of the United States to certify the ERA in contravention of multiple federal court rulings. -- support for Senate Resolution 107 (Hyde-Smith), expressing the sense of the Senate that Congress lacks power to act on a constitutional amendment resolution after submitting it to the states, or to revive an expired amendment proposal.
Contacts in opposition to proposed regulations, Regulations to Implement the Pregnant Workers Fairness Act, 88 Fed. Reg 54714 (August 11, 2023), (RIN): 3046-AB30) due to requirement that employers with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Filing targets: Drug Enforcement Administration (DEA), Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. These include: -- opposition to S.J. Res. 4 (Cardin) and H.J. Res. 25 (Pressley), resolutions purporting by multiple unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J. Res. 208 of the 92nd Congress, and to declare the long-expired 1972 Equal Rights Amendment to be part of the U.S. Constitution. (Cloture failed on motion to proceed to S. J. Res. 4, 51-47, on April 27, 2023.) -- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes by certain members of Congress and others to pressure the Archivist of the United States to certify the ERA in contravention of federal court rulings. -- support for Senate Resolution 107 (Hyde-Smith), expressing the sense of the Senate that Congress lacks power to act on a constitutional amendment resolution after submitting it to the states, or to revive an expired amendment proposal. Contacts of advisory and informational nature regarding the nomination of Colleen Shogan, Ph.D., as Archivist of the United States (PN 68), with respect to the status of the Equal Rights Amendment, and relating to the handling of Freedom of Information Act (FOIA) requests by the National Archives and Records Administration. No position taken on confirmation. Shogan confirmed 52-45 on May 10, 2023.
Contacts in support of proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation," 88 FR 12875 (March 1, 2023), (RIN): 1117-AB40, Docket ID DEA-407 due to impact of assisted suicide drugs. Contacts regarding vending machine dispensing of chemical abortion drugs.
Contacts regarding PEPFAR reauthorization over whether federal funds are going to funding recipients who also promote abortion.
Contacts in opposition to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn.
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY24 appropriations. Contacts in support of new riders including those related regulation of chemical abortion drugs, and others related to defunding the Department of Defense policy to pay for abortion-related travel.
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries. Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion (On this roll call vote, no. 90, on April 19, 2023, the vote failed).
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the U.S. House issued Jan, 10, 2023. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (H.R. 431) and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the U.S. House issued Jan, 10, 2023. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (H.R. 431) and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn.
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries. Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability. Contacts in opposition to proposed rule, Safeguarding the Rights of Conscience as Protected by Federal Statutes, 88 Fed. Reg. 820 (January 5, 2023), (RIN): 0945-AA18, Docket ID 2022-28505).
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of comments on March 1, 2023 DEA Rule Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation RIN: 1117-AB40 to prevent the prescription of lethal assisted suicide drugs on the basis of a telehealth visit only.
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY24 appropriations.
Contacts in regards to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services.
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Contacts in opposition to the Equality Act (H.R. 5/S. 393) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in opposition to the For the People Act of 2021 and Freedom to Vote Act (H.R. 1/S.1/S. 2093/S.2747/H.R. 5746/H.R. 2747 H.9/S.9) and similar legislation because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters.
Contacts in opposition to S. 1198, the Solid Start Act of 2022, due to language that could lead to the providing of abortion and abortion counseling. Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support and Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regard to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in regard to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (S. 4868/H.R. 8851 Providing for Life Act, H.R. 8384/S.4541 Standing with Moms Act, and others). Contacts in regards legislation to respond to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in opposition to the Build Back Better reconciliation bill (H.R. 5376). H.R. 5376 contains numerous provisions to fund elective abortion in violation of the longstanding principles of the Hyde Amendment, would mandate abortion funding in Affordable Care Act (Obamacare) plans in states that did not expand Medicaid in 2024, and direct billions of dollars to various public health grants without Hyde Amendment protections. Contacts in opposition to the Right to Contraception Act (H.R. 8373) which includes provisions related to the funding of abortion providers and includes language that could permit the use of drugs to induce an abortion weeks or months into a pregnancy. Contacts in opposition to H. Res. 1434 dealing with the preemption of state law in regard to abortion drugs. Contacts regarding H. R. 6878, the Pregnant Women in Custody Act, as it relates to travel for abortion. No position taken.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in regards to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2022 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of the No Abortion Bonds Act (H.R. 606) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers. Contacts in support of the Abortion is Not Health Care Act (S.124/H.R.380) to end the preferential tax treatment of abortion. Contacts in support of the Protecting Life in Health Savings Accounts Act (S. 125) to end the preferential tax treatment of abortion in health savings accounts.
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY23 appropriations. Contacts regarding NDAA (the National Defense Authorization Act) related to the funding of abortion.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2023 Foreign Operations appropriations vehicle. Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad. Contacts in opposition to the Global HER Act (H.R. 556/S.142) because it would permanently eliminate the "Mexico City Policy." Contacts in opposition to U.N. efforts regarding assertions that international human rights law should guide the Supreme Court, and claims that laws protecting unborn children are violations of the United States obligations under the human rights treaties it has signed and ratified. Contacts in regards to H.R. 5497, the BURMA Act, related to inclusion of the Helms Amendment. No position taken. Contacts in regards to H.R. 6968/H.Res. 972 with respect to the Global Magnitsky act and retaining the current definition of what constitutes a gross violations of internationally recognized human rights.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Contacts in opposition to the Equality Act (H.R. 5/S. 393) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in opposition to the For the People Act of 2021 and Freedom to Vote Act (H.R. 1/S.1/S. 2093/S.2747/H.R. 5746/H.R. 2747 H.9/S.9) and similar legislation because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections. Contacts in support of enforcing the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance, including support for a CRA (S.J.Res. 43/H.J.Res. 79)regarding Biden administration regulation. Contacts in regards to the Cures 2.0 legislation (H.R. 6000) with respect to abortion. Contacts in support of legislation (not introduces) to prohibit abortions from being counted as an eligible medical expense for Health Savings Accounts.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in opposition to S. 1198, the Solid Start Act of 2022, due to language that could lead to the providing of abortion and abortion counseling.
Contacts in support of retaining all current pro-life appropriations riders in FY23 appropriations. Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations. Contacts regarding NDAA (the National Defense Authorization Act) related to the funding of abortion.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2023 Foreign Operations appropriations vehicle. Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad. Contacts in opposition to the Global HER Act (H.R. 556/S.142) because it would permanently eliminate the "Mexico City Policy." Contacts in opposition to U.N. efforts regarding assertions that international human rights law should guide the Supreme Court, and claims that laws protecting unborn children are violations of the United States obligations under the human rights treaties it has signed and ratified. Contacts in regards to H.R. 5497, the BURMA Act, related to inclusion of the Helms Amendment. No position taken. Contacts in regards to H.R. 6968/H.Res. 972 with respect to the Global Magnitsky act and retaining the current definition of what constitutes a gross violations of internationally recognized human rights.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2022 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of the No Abortion Bonds Act (H.R. 606) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers. Contacts in support of the Abortion is Not Health Care Act (S.124/H.R.380) to end the preferential tax treatment of abortion. Contacts in support of the Protecting Life in Health Savings Accounts Act (S. 125) to end the preferential tax treatment of abortion in health savings accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2022 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn. Contacts in support of the No Abortion Bonds Act (H.R. 606) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers. Contacts in support of the Abortion is Not Health Care Act (S.124/H.R.380) to end the preferential tax treatment of abortion. Contacts in support of the Protecting Life in Health Savings Accounts Act (S. 125) to end the preferential tax treatment of abortion in health savings accounts.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age as well as similar legislation (not introduced). Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in regards to FDA oversight of prenatal testing products and efficacy. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regards to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regards to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs. Contacts in regards to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women. Contacts in regards to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in regards to the Central American Women and Children Protection Act of 2021 (H.R.4017). No position taken.
Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2023 Foreign Operations appropriations vehicle. Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad. Contacts in opposition to the Global HER Act (H.R. 556/S.142) because it would permanently eliminate the "Mexico City Policy." Contacts in opposition to U.N. efforts regarding assertions that international human rights law should guide the Supreme Court, and claims that laws protecting unborn children are violations of the United States obligations under the human rights treaties it has signed and ratified. Contacts in regards to H.R. 5497, the BURMA Act, related to inclusion of the Helms Amendment. No position taken. Contacts in regards to H.R. 6968/H.Res. 972 with respect to the Global Magnitsky act and retaining the current definition of what constitutes a gross violations of internationally recognized human rights.
Contacts in opposition to the Equality Act (H.R. 5/S. 393) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in opposition to the For the People Act of 2021 and Freedom to Vote Act (H.R. 1/S.1/S. 2093/S.2747/H.R. 5746/H.R. 2747 H.9/S.9) because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections. Contacts in support of enforcing the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance, including support for a CRA (S.J.Res. 43/H.J.Res. 79)regarding Biden administration regulation. Contacts in regards to the Cures 2.0 legislation (H.R. 6000) with respect to abortion. Contacts in support of legislation (not introduces) to prohibit abortions from being counted as an eligible medical expense for Health Savings Accounts.
Contacts in support of retaining all current pro-life appropriations riders in FY23 appropriations. Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations. Contacts in opposition to the "Build Back Better" reconciliation bill in current form due to funding of abortion in various healthcare programs. Contacts regarding NDAA (the National Defense Authorization Act) related to the funding of abortion.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2022 Foreign Operations appropriations vehicle. Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad. Contacts in opposition to the Global HER Act (H.R. 556/S.142) because it would permanently eliminate the "Mexico City Policy." Contacts in opposition to U.N. efforts regarding assertions that international human rights law should guide the Supreme Court, and claims that laws protecting unborn children are violations of the United States obligations under the human rights treaties it has signed and ratified. Contacts in regards to H.R. 5497, the BURMA Act, related to inclusion of the Helms Amendment. No position taken. Contacts in regards to H.R. 6968/H.Res. 972 with respect to the Global Magnitsky act and retaining the current definition of what constitutes a gross violations of internationally recognized human rights.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. This includes: -- opposition to H.J. Res. 17 and S.J. Res. 1, resolutions purporting by multiple unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J.Res. 208 of the 92nd Congress. -- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes to pressure the Archivist of the United States to certify the ERA in contravention of federal court rulings and the legal positions of the Department of Justice. -- opposition to H.Res. 891 (Speier), declaring "the sense of the House of Representatives" that the Equal Rights Amendment is part of the Constitution. -- opposition to H.J. Res. 28 (Maloney), "Proposing an amendment to the Constitution of the United States relative to equal rights for men and women." Contacts in opposition to the nomination of Ketanji Brown Jackson to the Supreme Court.
Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in regards to Care is an Economic Development Strategy Act or the CEDS Act (H.R. 5547) and potential abortion funding issues. No position taken.
Contacts in support of retaining all current pro-life appropriations riders in FY22 appropriations. Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations. Contacts in opposition to the "Build Back Better" reconciliation bill in current form due to funding of abortion in various healthcare programs. Contacts regarding NDAA (the National Defense Authorization Act) related to the funding of abortion.
Contacts in regards to the America Competes Act of 2022 (H.R. 4521) and whether healthcare tax credits could fund abortion services. No position taken this quarter.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections. Contacts in support of enforcing the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance, including support for a CRA (S.J.Res. 43/H.J.Res. 79)regarding Biden administration regulation. Contacts in regards to the Cures 2.0 legislation (H.R. 6000) with respect to abortion. Contacts in opposition to Robert Califf to the FDA due to issues related to loosening of restrictions on chemical abortion drugs. Contacts in support of legislation (not introduces) to prohibit abortions from being counted as an eligible medical expense for Health Savings Accounts. Contacts regarding the VIPER Act (H.R. 5721) in regards to concerns over use of fetal tissue in research.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age as well as similar legislation (not introduced). Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in regards to FDA oversight of prenatal testing products and efficacy. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3577) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regards to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. This includes opposition to H.J. Res. 17 and S.J. Res. 1, resolutions purporting by multiple unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J.Res. 208 of the 92nd Congress. This also includes contacts to encourage opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the Equal Rights Amendment. Contacts in opposition to H.J. Res. 28 (Maloney), "Proposing an amendment to the Constitution of the United States relative to equal rights for men and women." Contacts in opposition to H.R. 51 to grant statehood to D.C. due to constitutional concerns. Additionally, if D.C. were to become a state, the predictable result will be tax funding of hundreds (if not more) of elective abortions in D.C. annually. Contacts regarding a resolution (not introduced) concerning protecting parents rights in directing their childs education and potential impact on abortion.
Contacts in support of the Child Tax Credit for Pregnant Moms Act (not introduced) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the child's first year of life. Contacts in support of the No Abortion Bonds Act (H.R. 606) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers. Contacts in support of the Abortion is Not Health Care Act (S.124/H.R.380) to end the preferential tax treatment of abortion. Contacts in support of the Protecting Life in Health Savings Accounts Act (S. 125) to end the preferential tax treatment of abortion in health savings accounts. Contacts regarding legislation (not introduced) to provide still birth tax credit.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3577) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2022 Foreign Operations appropriations vehicle. Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad. Contacts in opposition to the Global HER Act (H.R. 556/S.142) because it would permanently eliminate the "Mexico City Policy." Contacts in opposition to U.N. efforts regarding assertions that international human rights law should guide the Supreme Court, and claims that laws protecting unborn children are violations of the United States obligations under the human rights treaties it has signed and ratified.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections. Contacts in support of enforcing the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in regards to the Cures 2.0 legislation (H.R. 6000) with respect to abortion. Contacts in opposition to Robert Califf to the FDA due to issues related to loosening of restrictions on chemical abortion drugs. Contacts in support of legislation (not introduces) to prohibit abortions from being counted as an eligible medical expense for Health Savings Accounts. Contacts regarding the VIPER Act (H.R. 5721) in regards to concerns over use of fetal tissue in research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Contacts in support of the Child Tax Credit for Pregnant Moms Act (not introduced) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the child's first year of life. Contacts in support of the No Abortion Bonds Act (H.R. 606) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers. Contacts in support of the Abortion is Not Health Care Act (S.124/H.R.380) to end the preferential tax treatment of abortion. Contacts in support of the Protecting Life in Health Savings Accounts Act (S. 125) to end the preferential tax treatment of abortion in health savings accounts. Contacts regarding legislation (not introduced) to provide still birth tax credit.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in opposition to the Equality Act (H.R. 5/S. 393) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in opposition to the For the People Act of 2021 (H.R. 1/S.1/S. 2093/S.2747) because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters.
Contacts in support of retaining all current pro-life appropriations riders in FY22 appropriations. Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations. Contacts in opposition to the "Build Back Better" reconciliation bill in current form due to funding of abortion in various healthcare programs.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2022 Foreign Operations appropriations vehicle. Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad. Contacts in opposition to the Global HER Act (H.R. 556/S.142) because it would permanently eliminate the "Mexico City Policy."
Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections. Contacts in support of enforcing the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123 ), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation (not introduced) to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620 ). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3577)which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Contacts in support of the Child Tax Credit for Pregnant Moms Act (not introduced) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the child's first year of life. Contacts in support of the No Abortion Bonds Act (H.R. 606) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers. Contacts in support of the Abortion is Not Health Care Act (S.124/H.R.380) to end the preferential tax treatment of abortion. Contacts in support of the Protecting Life in Health Savings Accounts Act (S. 125) to end the preferential tax treatment of abortion in health savings accounts.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. This includes opposition to H.J. Res. 17 and S.J. Res. 1, resolutions purporting by compound unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J.Res. 208 of the 92nd Congress. This also includes opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional impediments to resuscitation of the Equal Rights Amendment submitted to the states in 1972. Contacts in opposition to H.J. Res. 28 (Maloney), "Proposing an amendment to the Constitution of the United States relative to equal rights for men and women." Contacts in opposition to H.R. 51 to grant statehood to D.C. due to constitutional concerns. Additionally, if D.C. were to become a state, the predictable result will be tax funding of hundreds (if not more) of elective abortions in D.C. annually. Letter sent to the House April 19, 2021.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2022 Foreign Operations appropriations vehicle. Contacts in opposition to rolling back the Protecting Life in Global Health Assistance policy. Contacts in opposition to the Global HER Act (H.R. 556/S.142) because it would permanently eliminate the "Mexico City Policy."
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts regarding administrative changes to Medicare part D requiring step therapy and drug price capping based on a look-back period as it would relate to the delay or denial of life-saving medication. Contacts in opposition to administrative changes to International Price Indexing as it would base drug prices off of international prices that utilize the quality-adjusted-life year which is used to deny treatment to patients with ongoing medical needs and persons with disabilities.
Contacts in support of retaining all current pro-life appropriations riders in FY22 appropriations. Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations. Contacts regarding potential Senate Budget Resolution for FY2021, including potential amendments.
Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in opposition to the Equality Act (H.R. 5/S. 393 ) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in opposition to the For the People Act of 2021 (H.R. 1/S.1/S. 2093) because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters. Letter sent to the House February 8, 2021 (legislation passed) and letter sent to the Senate June 21,2021.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Council on Disability, SENATE
Contacts in support of retaining all current pro-life appropriations riders in FY22 appropriations. Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations. Contacts in opposition the COVID-19 reconciliation bill, known as the American Rescue Plan Act of 2021 (H.R. 1319) due to lack of language ensuring that programs do not fund elective abortion domestically or abroad, expansion of the Title X program, and expansion of Obamacare subsidies without Hyde-protections. Contacts in support of Lankford amendment to add Hyde-protections to provisions of the COVID-19 reconciliation bill, known as the American Rescue Plan Act of 2021 (H.R. 1319). Contacts in support of Sasse amendment #192 to S. Con. Res. 5, the Senate Budget Resolution for Fiscal Year 2021, would have created a deficit neutral reserve fund for legislation that would include the creation of criminal and civil penalties for providers who fail to exercise the same degree of care for babies who survive an abortion or attempted abortion as would be provided to another child born at the same gestational age.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2022 Foreign Operations appropriations vehicle. Contacts in opposition to rolling back the Protecting Life in Global Health Assistance policy. Contacts in opposition to the Global HER Act (H.R. 556/S.142) because it would permanently eliminate the "Mexico City Policy."
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123 ), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18) to codify government-wide policy against funding abortion. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation (not introduced) to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620 ). No position taken. Contacts in opposition to the Paycheck Fairness Act (H.R. 7) because the legislation addresses discrimination based on sex, and there is no rule of construction that would make this legislation abortion-neutral, it is likely that it could be used to sue employers for a lack of elective abortion coverage. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion.
Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans. Contacts in opposition to the nomination of Xavier Becerra to Secretary of Health and Human Services due to his abortion advocacy and lack of healthcare experience.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts regarding administrative changes to Medicare part D requiring step therapy and drug price capping based on a look-back period as it would relate to the delay or denial of life-saving medication. Contacts in opposition to administrative changes to International Price Indexing as it would base drug prices off of international prices that utilize the quality-adjusted-life year which is used to deny treatment to patients with ongoing medical needs and persons with disabilities.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. This includes opposition to H.J. Res. 17 and S.J. Res. 1, resolutions purporting by compound unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J.Res. 208 of the 92nd Congress. This also includes opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional impediments to resuscitation of the Equal Rights Amendment submitted to the states in 1972. Contacts in opposition to H.J. Res. 28 (Maloney), "Proposing an amendment to the Constitution of the United States relative to equal rights for men and women." Contacts in opposition to H.R. 51 to grant statehood to D.C. due to constitutional concerns. Additionally, if D.C. were to become a state, the predictable result will be tax funding of hundreds (if not more) of elective abortions in D.C. annually.
Contacts in opposition to the Equality Act (H.R. 5/S. 393 ) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in opposition to the For the People Act of 2021 (H.R. 1/S.1) because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters. Letter sent to the House February 8, 2021 (legislation passed).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Council on Disability, SENATE
Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in opposition to Medicare for All legislation (H.R. 1384 and S. 1129) because they mandate government coverage of abortions and are likely to require hospitals and doctors to perform abortion procedures. Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in opposition to H.R. 1425 which includes: 1) Permanent tax credit increases to the Patient Protection and Affordable Care Act; 2) A new federal reinsurance program run by states without Hyde-like protections; and 3) Prescription drug price controls that will lead to the rationing of treatment; letter to the House dated June 29, 2020. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in opposition to the Equality Act (H.R. 5) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in support of enforcement of the Americans with Disabilities Act as it would apply to states who permit legal assisted suicide in a discriminatory manner. Contacts in support of guidance from HHS and/or legislative language regarding discriminatory state and hospitals policies that would ration treatment based on age, degree of disability, and quality of life during Covid-19 pandemic. Contacts in support of administrative guidance related to the discriminatory use of the quality-adjusted life-year to deny treatment.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020. Contacts in support of administrative action enforcing existing EMTALA provisions regarding infact treatment and the Born-Alive Infant protection act to the fullest extent possible by law. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion. Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Consultations regarding letters of inquiry regarding whether abortion providers have violated various provisions of law regarding human fetal tissue sale or the partial birth abortion ban law. Contacts regarding a resolution condemning unwanted, unnecessary medical procedures on individuals without their full, informed consent (H. Res. 1154). No position taken. Contacts in support of legislation (not introduced) banning unwanted medical procedures. Contacts regarding the Pregnant Workers Fairness Act (H.R. 2694). No position taken. Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced). Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590). Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to enforce REMS during Covid-19 pandemic. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order. Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present. Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent. Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises. Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos. Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion. Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion. Contacts in opposition to the HEROES Act 2.0, which contains numerous provisions that permit funds to flow to the abortion industry as well as potentially funneling millions of dollars into programs without Hyde protections. Contacts in support of H.R. 6742, the Protecting Life in Crisis Act which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2021 Foreign Operations appropriations vehicle. Contacts in support of enforcement, and expansion of the Protecting Life in Global Health Assistance policy. Contacts in support of retaining pro-life policies in the Organization of American States. Contacts regarding the Women's Global Empowerment, Development and Prosperity Act of 2020 (S.3301) to ensure that the Helms and Siljander amendments apply to any funds. Contacts regarding abortion-related implications of H.R. 6117, the Women's Global Development and Prosperity Act of 2020. Contacts in opposition to codifying the Global Women's Initiative as a permanent office.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2019 (H.R. 2266/ S.1150) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the childs first year of life. Contacts in support of the No Abortion Bonds Act to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers. Contacts regarding IRS guidance and preferential tax treatment of costs associated with elective abortion as well as of plans that cover elective abortion.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by Congress in March 1972, with a ratification deadline that expired in March 1979. This includes opposition to H.J. Res. 79 and S.J. Res. 6 (purporting by unconstitutional mechanisms to nullify the ratification deadline contained in the joint resolution submitted to the states in 1972), and to any actions by which any organ of the Executive Branch would purport to recognize as viable the long-expired 1972 proposal. Opposition extends also to current text of H.J. Res 35 and S. J. Res. 15 (proposing re-submission of ERA language to the states, this time without a ratification deadline).
Contacts in support of nomination and/or confirmation of practitioners of judicial restraint to current and future vacancies on the federal courts, including the confirmation of Judge Amy Coney Barrett as Associate Justice of the United States Supreme Court. Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Council on Disability, Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts regarding administrative changes to Medicare part D requiring step therapy and drug price capping based on a look-back period as it would relate to the delay or denial of life-saving medication. Contacts in opposition to administrative changes to International Price Indexing as it would base drug prices off of international prices that utilize the quality-adjusted-life year which is used to deny treatment to patients with ongoing medical needs and persons with disabilities.
Contacts in support of nomination and/or confirmation of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Contacts in support of nomination and/or confirmation of practitioners of judicial restraint to current and future vacancies on the federal courts, including but not limited to the nomination and confirmation of Judge Amy Coney Barrett as Associate Justice of the United States Supreme Court. Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age including a letter to the Senate dated February 21, 2020. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020. Contacts in support of administrative action enforcing existing EMTALA provisions regarding infact treatment and the Born-Alive Infant protection act to the fullest extent possible by law. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion. Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Consultations regarding letters of inquiry regarding whether abortion providers have violated various provisions of law regarding human fetal tissue sale or the partial birth abortion ban law. Contacts regarding a resolution condemning unwanted, unnecessary medical procedures on individuals without their full, informed consent (H. Res. 1154). No position taken. Contacts in support of legislation (not introduced) banning unwanted medical procedures. Contacts regarding the Pregnant Workers Fairness Act (H.R. 2694). No position taken. Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced). Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590). Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to enforce REMS during Covid-19 pandemic. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order. Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present. Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent. Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises. Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos. Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion. Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion. Contacts in opposition to the HEROES Act 2.0, which contains numerous provisions that permit funds to flow to the abortion industry as well as potentially funneling millions of dollars into programs without Hyde protections. Contacts in support of H.R. 6742, the Protecting Life in Crisis Act which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in opposition to the Equality Act (H.R. 5) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in support of enforcement of the Americans with Disabilities Act as it would apply to states who permit legal assisted suicide in a discriminatory manner. Contacts in support of guidance from HHS and/or legislative language regarding discriminatory state and hospitals policies that would ration treatment based on age, degree of disability, and quality of life during Covid-19 pandemic. Contacts in support of administrative guidance related to the discriminatory use of the quality-adjusted life-year to deny treatment.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2021 Foreign Operations appropriations vehicle. Contacts in support of enforcement, and expansion of the Protecting Life in Global Health Assistance policy. Contacts in support of retaining pro-life policies in the Organization of American States. Contacts regarding the Women's Global Empowerment, Development and Prosperity Act of 2020 (S.3301) to ensure that the Helms and Siljander amendments apply to any funds. Contacts regarding abortion-related implications of H.R. 6117, the Women's Global Development and Prosperity Act of 2020.
Contacts in support of retaining all current pro-life appropriations riders and funding levels in FY21 appropriations. Contacts in opposition to the Consolidated Appropriations Act (H.R. 7608), including a letter dated July 24, 2020. Contacts in opposition to the Fiscal 2021 Defense Appropriations (H.R. 7617), including a letter dated July 29, 2020. Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations. Contacts in opposition to the Heroes Act 2.0.
Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in opposition to Medicare for All legislation (H.R. 1384 and S. 1129) because they mandate government coverage of abortions and are likely to require hospitals and doctors to perform abortion procedures. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in opposition to H.R. 1425 which includes: 1) Permanent tax credit increases to the Patient Protection and Affordable Care Act; 2) A new federal reinsurance program run by states without Hyde-like protections; and 3) Prescription drug price controls that will lead to the rationing of treatment; letter to the House dated June 29, 2020. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Council on Disability, Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
Contacts in opposition to the Equality Act (H.R. 5) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in support of enforcement of the Americans with Disabilities Act as it would apply to states who permit legal assisted suicide in a discriminatory manner. Contacts in support of guidance from HHS and/or legislative language regarding discriminatory state and hospitals policies that would ration treatment based on age, degree of disability, and quality of life during Covid-19 pandemic.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in opposition to Medicare for All legislation (H.R. 1384 and S. 1129) because they mandate government coverage of abortions and are likely to require hospitals and doctors to perform abortion procedures. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in opposition to H.R. 1425 which includes: 1) Permanent tax credit increases to the Patient Protection and Affordable Care Act; 2) A new federal reinsurance program run by states without Hyde-like protections; and 3) Prescription drug price controls that will lead to the rationing of treatment; letter to the House dated June 29, 2020. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections.
Contacts in support of nomination and/or confirmation of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age including a letter to the Senate dated February 21, 2020. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion. Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced). Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590). Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to enforce REMS during Covid-19 pandemic. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order. Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present. Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent. Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises. Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos. Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion. Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion. Contacts in opposition to H.R. 6800 (HEROS Act), which contains numerous provisions aimed at propping up the abortion industry as well as potentially funneling millions of dollars into programs without Hyde protections; letter to the House dated May 15, 2020. Contacts in support of H.R. 6742, the Protecting Life in Crisis Act which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
Contacts in support of retaining all current pro-life appropriations riders and funding levels in FY21 appropriations. Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts regarding administrative changes to Medicare part D requiring step therapy and drug price capping based on a look-back period as it would relate to the delay or denial of life-saving medication.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2020 any Foreign Operations appropriations vehicle. Contacts in support of enforcement of the Protecting Life in Global Health Assistance policy. Contacts in support of retaining pro-life policies in the Organization of American States. Contacts regarding abortion-related implications of H.R. 6117, the Women's Global Development and Prosperity Act of 2020.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states in March 1972, with a ratification deadline that expired in March 1979. Includes opposition to H.J. Res. 79 and H.J. Res. 6 (purporting by unconstitutional mechanisms to nullify the ratification deadline contained in the joint resolution submitted to the states in 1972). Opposition extends also to current text of H.J. Res 35 and S. J. Res. 15 (proposing re-submission of 1972 ERA language to the states, this time without a ratification deadline).
Contacts in opposition to the Equality Act (H.R. 5) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions. Contacts in support of enforcement of the Americans with Disabilities Act as it would apply to states who permit legal assisted suicide in a discriminatory manner. Contacts in support of guidance from HHS regarding discriminatory state and hospitals policies that would ration treatment based on age, degree of disability, and quality of life during Covid-19 pandemic.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2019 (H.R. 2266/ S.1150) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the childs first year of life. Contacts in support of the No Abortion Bonds Act (H.R.219) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers
Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in opposition to Medicare for All legislation (H.R. 1384 and S. 1129) because they mandate government coverage of abortions and are likely to require hospitals and doctors to perform abortion procedures. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2020 any Foreign Operations appropriations vehicle. Contacts in support of enforcement of the Protecting Life in Global Health Assistance policy. Contacts in support of retaining pro-life policies in the Organization of American States.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of nomination and/or confirmation of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age including a letter to the Senate dated February 21, 2020. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (S. 182/ H.R.2373 ) to prohibit discrimination against the unborn on the basis of sex. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion. Contacts in support of Child Interstate Abortion Notification Act (CIANA)(S. 119/ H.R.611), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of Child Custody Protection Act S.194/ H.R.2817), to prohibit transporting a minor across a state line to obtain an abortion without satisfying a parental involvement law in the minor's resident state. Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Title X Abortion Provider Prohibition Act (S. 105/H.R. 296) to make abortion providers ineligible to receive Title X family planning funds. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced). Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Responses to inquiries regarding the Ultrasound Informed Consent Act (H.R. 634), which provides that prior to an abortion, a provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting and display the ultrasound images so that the pregnant woman may view them. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590). Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to not roll back REMS during Covid-19 pandemic. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order. Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present. Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent. Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises. Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos. Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion. Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (S. 182/ H.R.2373 ) to prohibit discrimination against the unborn on the basis of sex. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion. Contacts in support of Child Interstate Abortion Notification Act (CIANA)(S. 119/ H.R.611), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of Child Custody Protection Act S.194/ H.R.2817), to prohibit transporting a minor across a state line to obtain an abortion without satisfying a parental involvement law in the minor's resident state. Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Title X Abortion Provider Prohibition Act (S. 105/H.R. 296) to make abortion providers ineligible to receive Title X family planning funds. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced). Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Responses to inquiries regarding the Ultrasound Informed Consent Act (H.R. 634), which provides that prior to an abortion, a provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting and display the ultrasound images so that the pregnant woman may view them. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590). Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of lifesustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order. Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present. Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent. Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Santity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises. Contacts in support of the Equal Right to Life Act (H.R.4442) to prohibit the prenatal genetic testing or abortion of an unborn child on the basis of the childs presumed sexual orientation. Contacts regarding the Patients First Act of 2019 (S.2308 /H.R.64) to direct HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos. Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states in March 1972, with a ratification deadline that expired in March 1979. Includes opposition to H.J. Res. 38, H.J. Res. 79, and H.J. Res. 6 (purporting by divergent unconstitutional mechanisms to nullify the ratification deadline contained in the joint resolution submitted to the states in 1972). Opposition extends also to current text of H.J. Res 35 and S. J. Res. 15 (proposing re-submission of 1972 ERA language to the states, this time without a ratification deadline).
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in opposition to the For the People Act of 2019 (H.R. 1) because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters. Letter sent to the House March 5, 2019. Contacts in opposition to the "Shield Act" (H.R. 4617) as it would make it difficult for corporations (including nonprofit, issue-oriented corporations such as NRLC) to engage in non-political campaigns. H.R. 4617 would likely impose burdensome requirements on non-election advertisements (digital or broadcast) would be subject to new burdensome disclaimer and reporting requirements from the FEC. Letter sent to the House dated October 22, 2019. Contacts in opposition to the Equality Act (H.R. 5) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions, including a letter to the House dated May 9, 2019. Contacts in support of enforcement of the Americans with Disabilities Act as it would apply to states who permit legal assisted suicide in a discriminatory manner.
Contacts in support of nomination and/or confirmation of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2019 (H.R. 2266/ S.1150) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the childs first year of life. Contacts in support of the No Abortion Bonds Act (H.R.219) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers
Contacts regarding advance care planning legislation (not introduced) to (1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, (2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, (3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act, (4) include oversight for grant approval for physician orders for life-sustaining treatment, and (5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in opposition to Medicare for All legislation (H.R. 1384 and S. 1129) because they mandate government coverage of abortions and are likely to require hospitals and doctors to perform abortion procedures. Contacts in opposition to the "Lower Drug Costs Now Act of 2019" (H.R. 3) because it will prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market, including a letter dated December 10, 2019 sent to the House.
Contacts in support of retaining all current pro-life appropriations riders and funding levels in FY20 appropriations.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2020 any Foreign Operations appropriations vehicle. Contacts in support of enforcement of the Protecting Life in Global Health Assistance policy.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2019 (H.R. 2266/ S.1150) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the childs first year of life.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (S. 182) to prohibit discrimination against the unborn on the basis of sex or race. Contacts regarding legislation, not introduced, to prohibit discrimination against the unborn on the basis of disability. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 462/S. 311), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion. Contacts in support of Child Interstate Abortion Notification Act (CIANA)(S. 119), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 708/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding Defund Planned Parenthood Act (H.R. 369) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Title X Abortion Provider Prohibition Act (S. 105/H.R. 296) to make abortion providers ineligible to receive Title X family planning funds. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Consultations regarding legislation to improve abortion reporting, not introduced; no specific legislation endorsed during this quarter. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions; no specific legislation endorsed during this quarter. Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of H.R. 2010, the Second Chance at Life Act to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Responses to inquiries regarding the Ultrasound Informed Consent Act (H.R. 634), which provides that prior to an abortion, a provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting and display the ultrasound images so that the pregnant woman may view them. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of the Protecting the Dignity of Unborn Children Act of 2019 (H.R. 671) to prohibit recklessly disposing of or abandoning fetal remains. Contacts in support of the Dignity for Aborted Children Act (S. 2590) to require any abortion provider to provide the patient with an informed consent form, offering the patient options for disposal of the human fetal tissue from the abortion. Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Contacts in support of legislation, not introduced, restricting the use of telemedicine to provide abortion. Contacts in support of the Ensuring Accurate and Complete Abortion Data Reporting Act of 2019 (H.R.3580) to incentivize states to report certain abortion-related data to the CDC.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts regarding the Medicare Choices Empowerment and Protection Act (S. 618), to give beneficiaries and others online access to model advance directives that choose life-saving treatment, food and fluids equally with those that reject them in order to offset widespread efforts to nudge patients to agree to forego life-saving treatment. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts regarding administrative changes to Medicare part D requiring step therapy and drug price capping based on a look-back period as it would relate to the delay or denial of life-saving medication. Contacts regarding the Older Americans Act reauthorization as it would relate to the pressuring patients to reject treatment against their wishes. No position taken this quarter.
Contacts in support of retaining all current pro-life appropriations riders in FY20 appropriations. Contacts regarding the "Bipartisan Budget Act of 2019."
Contacts in support of nomination of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Contacts in opposition to allowing dilatory post-cloture procedures on such nominations. Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that was submitted to the states in March 1972, with a ratification deadline that expired in March 1979. Opposition includes but is not limited to H.J. Res 35 and S. J. Res. 15 (proposing re-submission of 1972 ERA language to the states, this time without a ratification deadline); H.J. Res. 38 and H.J. Res. 6 (purporting to nullify the ratification deadline contained in the joint resolution submitted to the states in 1972, retroactively); and H. Res. 272 (expressing the view of the House of Representatives that the language of the 1972 ERA submission should be made part of the U.S. Constitution).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2019 (H.R. 2266/ S.1150) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the childs first year of life.
Contacts in opposition to H.R. 1425 the State Health Care Premium Reduction Act of 2019 due to appropriations of funds for states to use for cost-sharing reductions and reinsurance without necessary "Hyde Amendment" protections to prevent the funds from flowing to insurance plans that cover elective abortion. Contacts regarding advance care planning legislation (not introduced) to (1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, (2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, (3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act, (4) include oversight for grant approval for physician orders for life-sustaining treatment, and (5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in opposition to Medicare for All legislation (H.R. 1384 and S. 1129) because they mandate government coverage of abortions and are likely to require hospitals and doctors to perform abortion procedures.
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that was submitted to the states in March 1972, with a ratification deadline that expired in March 1979. Opposition includes but is not limited to H.J. Res 35 and S. J. Res. 15 (proposing re-submission of 1972 ERA language to the states, this time without a ratification deadline); H.J. Res. 38 and H.J. Res. 6 (purporting to nullify the ratification deadline contained in the joint resolution submitted to the states in 1972, retroactively); and H. Res. 272 (expressing the view of the House of Representatives that the language of the 1972 ERA submission should be made part of the U.S. Constitution).
Contacts in support of nomination of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Contacts in opposition to allowing dilatory post-cloture procedures on such nominations. Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2019 any Foreign Operations appropriations vehicle. Contacts in support of enforcement of the Protecting Life in Global Health Assistance policy.
Contacts in opposition to the For the People Act of 2019 (H.R. 1) because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters. Letter sent to the House March 5, 2019. Contacts in opposition to the Equality Act (H.R. 5) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions, including a letter to the House dated May 9, 2019.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (S. 182) to prohibit discrimination against the unborn on the basis of sex or race. Contacts regarding legislation, not introduced, to prohibit discrimination against the unborn on the basis of disability. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 462/S. 311), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion including a letter to the Senate dated January 16th, 2019. (The Senate failed to advance the legislation.) Contacts in support of Child Interstate Abortion Notification Act (CIANA)(S. 119), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 708/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding Defund Planned Parenthood Act (H.R. 369) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Title X Abortion Provider Prohibition Act (S. 105/H.R. 296) to make abortion providers ineligible to receive Title X family planning funds. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Consultations regarding legislation to improve abortion reporting, not introduced; no specific legislation endorsed during this quarter. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions; no specific legislation endorsed during this quarter. Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of H.R. 2010, the Second Chance at Life Act to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Responses to inquiries regarding the Ultrasound Informed Consent Act (H.R. 634), which provides that prior to an abortion, a provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting and display the ultrasound images so that the pregnant woman may view them. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of a new Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of the Ensuring Accurate and Complete Abortion Data Reporting Act of 2019 (H.R.3580) to incentivize states to report certain abortion-related data to the CDC.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts regarding the Medicare Choices Empowerment and Protection Act (S. 618), to give beneficiaries and others online access to model advance directives that choose life-saving treatment, food and fluids equally with those that reject them in order to offset widespread efforts to nudge patients to agree to forego life-saving treatment. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts regarding administrative changes to Medicare part D requiring step therapy and drug price capping based on a look-back period as it would relate to the delay or denial of life-saving medication.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
Contacts in support of including "Hyde Amendment" protections on any funds that might be appropriated, and to any efforts to stabilize Obamacare healthcare markets in the FY19 appropriations. Contacts in support of retaining all current pro-life appropriations riders in FY19 appropriations. Contacts in opposition to the Consolidated Appropriations Act, 2019 covering various federal programs because it contained language that would effectively overturn the current pro-life Protecting Life in Global Health Assistance program. Letter sent to the House dated January 3, 2019.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2019 any Foreign Operations appropriations vehicle. Contacts in support of enforcement of the Protecting Life in Global Health Assistance policy.
Contacts in support of nomination of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Contacts in opposition to allowing dilatory post-cloture procedures on such nominations.
Contacts in opposition to H.R. 1425 the State Health Care Premium Reduction Act of 2019 due to appropriations of funds for states to use for cost-sharing reductions and reinsurance without necessary "Hyde Amendment" protections to prevent the funds from flowing to insurance plans that cover elective abortion. Contacts regarding advance care planning legislation (not introduced) to (1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, (2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, (3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act, (4) include oversight for grant approval for physician orders for life-sustaining treatment, and (5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in opposition to Medicare for All legislation H.R. 1384 and S. 1129 because they mandate government coverage of abortions and are likely to require hospitals and doctors to perform abortion procedures.
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (S. 182) to prohibit discrimination against the unborn on the basis of sex or race. Contacts regarding legislation, not introduced, to prohibit discrimination against the unborn on the basis of disability. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 462/S. 311), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the House urging signing of a discharge petition dated March 27,2019, and a letter to the Senate dated February 21, 2019. (The Senate failed to advance the legislation.) Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion including a letter to the Senate dated January 16th, 2019. (The Senate failed to advance the legislation.) Contacts in support of Child Interstate Abortion Notification Act (CIANA)(S. 119), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 708/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding Defund Planned Parenthood Act (H.R. 369) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Title X Abortion Provider Prohibition Act (S. 105/H.R. 296) to make abortion providers ineligible to receive Title X family planning funds. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Consultations regarding legislation to improve abortion reporting, not introduced; no specific legislation endorsed during this quarter. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions; no specific legislation endorsed during this quarter. Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of H.R. 2010, the Second Chance at Life Act to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Responses to inquiries regarding the Ultrasound Informed Consent Act (H.R. 634), which provides that prior to an abortion, a provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting and display the ultrasound images so that the pregnant woman may view them. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of a new Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts supporting a veto and sustaining of veto of any bill that weakens any existing pro-life policy. Contacts regarding certain provisions of the "Violence Against Women Reauthorization Act of 2019" (H.R.1585) and impact on counseling against abortion; no position taken.
Contacts in opposition to the For the People Act of 2019 (H.R. 1) because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters. Letter sent to the House March 5, 2019.
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2019 (H.R. 2266/ S.1150) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the childs first year of life.
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page.
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page. Contacts in support of the Medicare Choices Empowerment and Protection Act (S. 1530/H.R. 3181), to give beneficiaries and others online access to model advance directives that choose life-saving treatment, food and fluids equally with those that reject them in order to offset widespread efforts to nudge patients to agree to forego life-saving treatment.
Contacts in support of language to the FY 2019 State, Foreign operations appropriations bill to create funding limitation on organizations that promote or perform abortion and organizations that participate in coercive abortion programs. Consultations regarding FY 2019 appropriations measures, including support for retention of all current pro-life limitation amendments and other pro-life provisions. Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2018 (H.R. 5006, S. 2420), to extend child tax credit to cover unborn children.
For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R. 4660, S. 2326), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 4712, S. 220), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the House dated January 16, 2018, and a letter to the House on Rule resolution H. Res. 694 dated January 17, 2018. (The House passed the bill on January 17, 2018.) Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 644, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in response to inquiries regarding the Heartbeat Bill (H.R.490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Patients First Act (H.R. 2918) to require the federal National Institutes of Health to intensify research on types of stem-cell research that do not involve harming human embryos. Responses to inquiries regarding "Life at Conception Act" (H.R. 681, S. 231); nonsupport due to lack of clarity and erroneous legal premises. Contracts regarding abortion-pill reversal and informed consent requirements. Legislation not introduced. Contacts regarding the Maternal Health Accountability Act (S. 1112 and H.R. 1318), related to reporting factors, contract grantee criteria, and potential issues surrounding recommending expansion of abortion access. No position taken this quarter. Contacts in support of a letter requesting that HHS issue new Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts regarding the Protecting Health and Wellness of Babies and Pregnant Women in Custody Act (H.R. 6085) as related to potential issues regarding abortion. No position taken this quarter.   Contacts regarding the Quality Care for Moms and Babies Act (S.2637/H.R.5457) as related to potential issues regarding abortion. No position taken this quarter. Supported veto and sustaining of veto of any bill that weakens any existing pro-life policy.  
For activity pertaining to budget reconciliation legislation, see also the BUD (Budget/Appropriations) page. Contacts in support of certain provisions for incorporation into health care reform ("repeal and replace") legislation, including: elimination of multiple abortion-subsiding and abortion-expanding components of PL 111-148; inclusion of strong language to prevent federal subsidies of elective abortion coverage; retention of untaxed and uncapped private health insurance coverage, including postponement or nullification of the so-called "Cadillac tax" of PL 111-148; no limitation on what Americans can spend from private resources on health care; and strengthen provisions in PL 111-148 to enforce the segregation of funds for abortion services. Contacts regarding advance care planning legislation (not introduced) to (1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, (2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, (3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act, (4) include oversight for grant approval for physician orders for life-sustaining treatment, and (5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding potential legislation related to strengthening Federal policy against physician-assisted suicide. Contacts in support of H.Con.Res. 80, expressing the sense of the Congress that assisted suicide puts vulnerable patients at risk and undermines the integrity of the health care system. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts in support of H.R. 4131 (Pittenger) to amend the Internal Revenue Code to impose federal taxes on bonds used to provide facilities owned by abortion providers. Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts regarding H.R. 3119, the "Palliative Care and Hospice Education and Training Act," as to whether provisions of the Assisted Suicide Funding Restriction Act would be impacted or if there were potential involuntary denial-of-treatment issues.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
For activity pertaining to budget reconciliation legislation, see also the BUD (Budget/Appropriations) page. Contacts in support of certain provisions for incorporation into health care reform ("repeal and replace") legislation, including: elimination of multiple abortion-subsiding and abortion-expanding components of PL 111-148; inclusion of strong language to prevent federal subsidies of elective abortion coverage; retention of untaxed and uncapped private health insurance coverage, including postponement or nullification of the so-called "Cadillac tax" of PL 111-148; no limitation on what Americans can spend from private resources on health care; and strengthen provisions in PL 111-148 to enforce the segregation of funds for abortion services. Contacts regarding advance care planning legislation (not introduced) to (1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, (2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, (3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act, (4) include oversight for grant approval for physician orders for life-sustaining treatment, and (5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding potential legislation related to strengthening Federal policy against physician-assisted suicide. Contacts in support of H.Con.Res. 80, expressing the sense of the Congress that assisted suicide puts vulnerable patients at risk and undermines the integrity of the health care system. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts in support of H.R. 4131 (Pittenger) to amend the Internal Revenue Code to impose federal taxes on bonds used to provide facilities owned by abortion providers. Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts regarding H.R. 3119, the "Palliative Care and Hospice Education and Training Act," as to whether provisions of the Assisted Suicide Funding Restriction Act would be impacted or if there were potential involuntary denial-of-treatment issues.
For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R. 4660, S. 2326), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 4712, S. 220), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the House dated January 16, 2018, and a letter to the House on Rule resolution H. Res. 694 dated January 17, 2018. (The House passed the bill on January 17, 2018.) Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 644, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in response to inquiries regarding the Heartbeat Bill (H.R.490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Patients First Act (H.R. 2918) to require the federal National Institutes of Health to intensify research on types of stem-cell research that do not involve harming human embryos. Responses to inquiries regarding "Life at Conception Act" (H.R. 681, S. 231); nonsupport due to lack of clarity and erroneous legal premises. Contracts regarding abortion-pill reversal and informed consent requirements. Legislation not introduced. Contacts regarding the Maternal Health Accountability Act (S. 1112 and H.R. 1318), related to reporting factors, contract grantee criteria, and potential issues surrounding recommending expansion of abortion access. No position taken this quarter. Contacts in support of a letter requesting that HHS issue new Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts regarding the Protecting Health and Wellness of Babies and Pregnant Women in Custody Act (H.R. 6085) as related to potential issues regarding abortion. No position taken this quarter.   Contacts regarding the Quality Care for Moms and Babies Act (S.2637/H.R.5457) as related to potential issues regarding abortion. No position taken this quarter.  
Contacts in support of nomination of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Contacts is support timely committee and floor action on such nominees. Contacts pertaining to U.S. Supreme Court vacancy created by the resignation of Associate Justice Anthony Kennedy, and contacts in support of confirmation of Judge Brett Kavanaugh as successor Associate Justice (confirmed, Oct. 6, 2018). Consultations regarding legislation purporting to expand safe harbor for election-related speech by churches; no position on the legislation in the form introduced as the Free Speech Fairness Act (H.R. 781, S. 264).
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page. Contacts in support of the Medicare Choices Empowerment and Protection Act (S. 1530/H.R. 3181), to give beneficiaries and others online access to model advance directives that choose life-saving treatment, food and fluids equally with those that reject them in order to offset widespread efforts to nudge patients to agree to forego life-saving treatment.
Contacts in opposition to H.J. Res. 33, S.J.Res.6, proposing to add certain language termed an "Equal Rights Amendment" to the U.S. Constitution, unless an "abortion-neutral amendment" is added. Contacts in opposition to legislative or executive actions to buttress the constitutionally flawed notion ("three-state theory") that the long-dead 1972 "Equal Rights Amendment" is still pending before the state legislatures for potential ratification, including but not limited to opposition to H.J.Res 53 and S.J.Res 5, resolutions embracing the erroneous concept that Congress can pass ex post facto legislation declaring inoperative the ratification deadline contained in the 1972 ERA resolution.
Contacts in support of language to the FY 2019 State, Foreign operations appropriations bill to create funding limitation on organizations that promote or perform abortion and organizations that participate in coercive abortion programs. Consultations regarding FY 2019 appropriations measures, including support for retention of all current pro-life limitation amendments and other pro-life provisions, including a letter to the Senate dated August 23, 2018 in support of the Paul Amendment to deny federal funds to abortion providers (amendment failed). Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2018 (H.R. 5006, S. 2420), to extend child tax credit to cover unborn children.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2018 continuing resolution and any other Foreign Operations appropriations vehicle. Contacts in opposition to S. 210, to remove the authority of the President to apply certain conditions to U.S. funds directed to foreign nongovernmental organizations. Response to inquiries regarding S. 1730, the Reach Every Mother and Child Act of 2017, which directs the President to establish a five-year strategy to achieve the goal of ending preventable child and maternal deaths globally and ensure healthy and productive lives by 2030. No position taken this quarter. Contacts in support of eliminating abortion language in Organization of American States document from June 4th at Forty-Eighth Regular Session of the General Assembly. Offending language was eliminated.
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page. Contacts in support of the Medicare Choices Empowerment and Protection Act (S. 1530/H.R. 3181), to give beneficiaries and others online access to model advance directives that choose life-saving treatment, food and fluids equally with those that reject them in order to offset widespread efforts to nudge patients to agree to forego life-saving treatment.
Contacts in support of nomination of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Contacts is support of adjustments in committee and floor procedures to allow timely processing of nominations. Consultations regarding legislation purporting to expand safe harbor for election-related speech by churches; no position on the legislation in the form introduced as the Free Speech Fairness Act (H.R. 781, S. 264).
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page.
Contacts in support of including "Hyde Amendment" protections on any funds that might be appropriated to stabilize Obamacare healthcare markets such as those found in S.1835, the Lower Premiums Through Reinsurance Act of 2017 (Collins) and The Bipartisan Health Care Stabilization Act of 2017 (Alexander). Contacts in support of language to the FY 2019 State, Foreign operations appropriations bill to create funding limitation on organizations that promote or perform abortion and organizations that participate in coercive abortion programs. Consultations regarding possible amendments for FY 2019 appropriations measures, including support for retention of all current pro-life limitation amendments and other pro-life provisions. Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2018 (H.R. 5006, S. 2420), to extend child tax credit to cover unborn children. Contacts in regards to the FY 2019 Financial Services appropriations bill related to ICE detainees and access to abortion services. Consultations regarding use of the Congressional Budget Impound Act with regards to use to reduce funding of clinics that provide elective abortion. (Not introduced.) Contacts regarding FY18 Omnibus Appropriations Act (H.R. 1625) to clarify that while the FY18 omnibus did not include new pro-life measures, it did retain all previously enacted pro-life limitation riders and did not include any "line item" designating money for abortion providers including Planned Parenthood.
For activity pertaining to budget reconciliation legislation, see also the BUD (Budget/Appropriations) page. Contacts in support of certain provisions for incorporation into health care reform ("repeal and replace") legislation, including: elimination of multiple abortion-subsiding and abortion-expanding components of PL 111-148; inclusion of strong language to prevent federal subsidies of elective abortion coverage; retention of untaxed and uncapped private health insurance coverage, including postponement or nullification of the so-called "Cadillac tax" of PL 111-148; no limitation on what Americans can spend from private resources on health care; and strengthen provisions in PL 111-148 to enforce the segregation of funds for abortion services. Contacts regarding advance care planning legislation (not introduced) to (1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, (2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, (3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act, (4) include oversight for grant approval for physician orders for life-sustaining treatment, and (5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding potential legislation related to strengthening Federal policy against physician-assisted suicide. Contacts in support of H.Con.Res. 80, expressing the sense of the Congress that assisted suicide puts vulnerable patients at risk and undermines the integrity of the health care system. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts in support of H.R. 4131 (Pittenger) to amend the Internal Revenue Code to impose federal taxes on bonds used to provide facilities owned by abortion providers. Contacts regarding H.R. 3922 to extend community health center funding and potential impact on funding for elective abortion. Contacts in support of adding "Hyde Amendment" protections to prevent allowing funds to flow to health plans that cover elective abortions to the Bipartisan Health Care Stabilization Act of 2017 and the Lower Premiums Through Reinsurance Act of 2017(S.1835). Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in support of Graham-Cassidy proposal to convert the Obama Health law federal subsidies to state block grants that would be protected by the Hyde amendments restriction on funding elective abortion.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2018 continuing resolution and any other Foreign Operations appropriations vehicle. Contacts in opposition to S. 210, to remove the authority of the President to apply certain conditions to U.S. funds directed to foreign nongovernmental organizations. Response to inquiries regarding S. 1730, the Reach Every Mother and Child Act of 2017, which directs the President to establish a five-year strategy to achieve the goal of ending preventable child and maternal deaths globally and ensure healthy and productive lives by 2030. No position taken this quarter.
For activity pertaining to budget reconciliation legislation, see also the BUD (Budget/Appropriations) page. Contacts in support of certain provisions for incorporation into health care reform ("repeal and replace") legislation, including: elimination of multiple abortion-subsiding and abortion-expanding components of PL 111-148; inclusion of strong language to prevent federal subsidies of elective abortion coverage; retention of untaxed and uncapped private health insurance coverage, including postponement or nullification of the so-called "Cadillac tax" of PL 111-148; no limitation on what Americans can spend from private resources on health care; and strengthen provisions in PL 111-148 to enforce the segregation of funds for abortion services. Contacts regarding advance care planning legislation (not introduced) to (1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, (2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, (3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act, (4) include oversight for grant approval for physician orders for life-sustaining treatment, and (5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding potential legislation related to strengthening Federal policy against physician-assisted suicide. Contacts in support of H.Con.Res. 80, expressing the sense of the Congress that assisted suicide puts vulnerable patients at risk and undermines the integrity of the health care system. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts in support of H.R. 4131 (Pittenger) to amend the Internal Revenue Code to impose federal taxes on bonds used to provide facilities owned by abortion providers. Contacts in support of Protecting Seniors' Access to Medicare Act of 2017 (H.R.849/S.260) to repeal the Independent Payment Advisory Board, a component of PL 111-148 with power to suppress nongovernmental health care spending by limiting treatments that doctors are allowed to give their patients including a letter to the House dated October 30, 2017 (the measure passed the House 11/02/2017). Contacts in support of the inclusion of this legislation in the Bipartisan Budget Act and the CR for FY for FY 18, including a letter to Congress dated February 8, 2018 (this measure became law). Contacts regarding H.R. 3922 to extend community health center funding and potential impact on funding for elective abortion. Contacts in support of adding "Hyde Amendment" protections to prevent allowing funds to flow to health plans that cover elective abortions to the Bipartisan Health Care Stabilization Act of 2017 and the Lower Premiums Through Reinsurance Act of 2017(S.1835). Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in support of Graham-Cassidy proposal to convert the Obama Health law federal subsidies to state block grants that would be protected by the Hyde amendments restriction on funding elective abortion.
Contacts in support of nomination of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts including nomination of Stuart Kyle Duncan to U.S. Court of Appeals for the 5th Circuit. Contacts advocating streamlining of committee and floor procedures for processing nominations. Consultations regarding legislation purporting to expand safe harbor for election-related speech by churches; no position on the legislation in the form introduced as the Free Speech Fairness Act (H.R. 781, S. 264).
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page. Contacts regarding the Healthy Kids Act (H.R. 3921), which reauthorizes the CHIP program with regards to blended risk pools for privately funded CHIP look-alike healthcare plans.
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page. Contacts in support of the Medicare Choices Empowerment and Protection Act (S. 1530/H.R. 3181), to give beneficiaries and others online access to model advance directives that choose life-saving treatment, food and fluids equally with those that reject them in order to offset widespread efforts to nudge patients to agree to forego life-saving treatment.
Contacts in opposition to H.J. Res. 33, S.J.Res.6, proposing to add certain language termed an "Equal Rights Amendment" to the U.S. Constitution, unless an "abortion-neutral amendment" is added. Contacts in opposition to H.J.Res 53, S.J.Res 5, resolutions embracing the erroneous concept that the long-dead 1972 "Equal Rights Amendment" can still be ratified by new states if Congress passes ex post facto legislation declaring inoperative the ratification deadline contained in the 1972 resolution.
Contacts in support of including "Hyde Amendment" protections on any funds that might be appropriated to stabilize Obamacare healthcare markets in the omnibus FY18 appropriations, including appropriations linked to provisions such as those found in S.1835, the Lower Premiums Through Reinsurance Act of 2017 (Collins) and The Bipartisan Health Care Stabilization Act of 2017 (Alexander). However, ultimately such funds were not included in the legislation. Contacts in support of inclusion of H.R. 644, the Conscience Protection Act, in the omnibus FY18 appropriations bill. (The language was not included.) Contacts in opposition to inclusion of language in the omnibus FY18 appropriations bill to prohibit future changes to regulations governing Title X of the Public Health Service Act. (The language was not included.) Contacts in support of language to the FY 2019 State, Foreign operations appropriations bill to create funding limitation on organizations that promote or perform abortion and organizations that participate in coercive abortion programs. Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2018 (H.R. 5006, S. 2420), to extend child tax credit to cover unborn children. Contacts in regards to the FY 2019 Financial Services appropriations bill related to ICE detainees and access to abortion services. Contacts in support of retaining the adoption tax credit as well as the exclusion for adoption assistance programs (section 1406) in H.R. 1, the Tax Cuts and Jobs Act of 2017. (The adoption tax credit was retained.)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page. Contacts regarding the Healthy Kids Act (H.R. 3921), which reauthorizes the CHIP program with regards to blended risk pools for privately funded CHIP look-alike healthcare plans.
For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (H.R. 36, S. 1922), to protect pain-capable unborn children beginning at 20 weeks fetal age including a letter to the House dated September 27, 2017 (the House passed the measure on October 3, 2017). Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R.147/H.R.4660), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 37, H.R. 4712, S. 220), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital. Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 644, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding Defund Planned Parenthood Act (H.R.853) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Defund Planned Parenthood Act (H.R. 354, S.241), to deny for one year the availability of federal funds to Planned Parenthood affiliates or clinics that provide elective abortion. Activity on budget reconciliation bill pertaining to Planned Parenthood reported on BUD (Budget/Appropriations) page. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in support of the Every Child is a Blessing Act (H.R. 684), to eliminate wrongful birth and wrongful life" lawsuits, when they arise under federal law or from claims involving health care services affecting interstate or foreign commerce. Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts expressing support for addition of language to prevent subsidies for abortion and other pro-life components in proposed legislation to revise laws dealing with health benefits for Peace Corps volunteers (H.R. 2259 and S. 2286). Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Patients First Act (H.R. 2918) to require the federal National Institutes of Health to intensify research on types of stem-cell research that do not involve harming human embryos. Responses to inquiries regarding "Life at Conception Act" (H.R. 681, S. 231); nonsupport due to lack of clarity and erroneous legal premises.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2018 continuing resolution and any other Foreign Operations appropriations vehicle. Contacts in support of nomination of pro-life ambassador to Haiti. Contacts in opposition to S. 210, to remove the authority of the President to apply certain conditions to U.S. funds directed to foreign nongovernmental organizations.
For activity pertaining to budget reconciliation legislation, see also the BUD (Budget/Appropriations) page. Contacts in support of certain provisions for incorporation into health care reform ("repeal and replace") legislation, including the Senate Better Care Replacement Act, including: elimination of multiple abortion-subsiding and abortion-expanding components of PL 111-148; inclusion of strong language to prevent federal subsidies of elective abortion coverage; retention of untaxed and uncapped private health insurance coverage, including postponement or nullification of the so-called "Cadillac tax" of PL 111-148; no limitation on what Americans can spend from private resources on health care; and strengthen provisions in PL 111-148 to enforce the segregation of funds for abortion services. Contacts regarding advance care planning legislation (not introduced) to (1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, (2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, (3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act, (4) include oversight for grant approval for physician orders for life-sustaining treatment, and (5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding potential legislation related to strengthening Federal policy against physician-assisted suicide. Contacts in support of H.Con.Res. 80, expressing the sense of the Congress that assisted suicide puts vulnerable patients at risk and undermines the integrity of the health care system. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts in support of strengthening regulations surrounding implementation of certain elements of PL 111-148 related to the segregation of funds for elective abortion. Contacts in support of H.R.4131 (Pittenger) to amend the Internal Revenue Code to impose federal taxes on bonds used to provide facilities owned by abortion providers. Contacts regarding the Protecting Access to Care Act of 2017 (H.R. 1215), pertaining to caps to damages arising from the intentional denial of treatment along with possible preemption issues related to state law; no position taken this quarter. Contacts in support of Protecting Seniors' Access to Medicare Act of 2017 (H.R.849/S.260) to repeal the Independent Payment Advisory Board, a component of PL 111-148 that has power to suppress nongovernmental health care spending by limiting treatments that doctors are allowed to give their patients including a letter to the House dated October 30 (the measure passed the House 11/02/2017) Contacts regarding H.R. 3922 to extend community health center funding and potential impact on funding for elective abortion. Contacts in support of adding "Hyde Amendment" protections to prevent allowing funds to flow to health plans that cover elective abortions to the Bipartisan Health Care Stabilization Act of 2017 and the Lower Premiums Through Reinsurance Act of 2017(S.1835). Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in support of Graham-Cassidy proposal to convert the Obama Health law federal subsidies to state block grants that would be protected by the Hyde amendments restriction on funding elective abortion.
Contacts in opposition to H.J. Res. 33, S.J.Res.6, proposing to add certain language termed an "Equal Rights Amendment" to the U.S. Constitution, unless an "abortion-neutral amendment" is added. Contacts in opposition to H.J.Res 53, S.J.Res 5, resolutions embracing the erroneous concept that the long-dead 1972 "Equal Rights Amendment" can still be ratified by new states if Congress passes ex post facto legislation declaring inoperative the ratification deadline contained in the 1972 resolution.
Contacts in support of nomination of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts including nomination of Stuart Kyle Duncan to U.S. Court of Appeals for the 5th Circuit. Contacts advocating streamlining of committee and floor procedures for processing nominations. Consultations regarding legislation purporting to expand safe harbor for election-related speech by churches; no position on the legislation in the form introduced as the Free Speech Fairness Act (H.R. 781, S. 264).
Contacts in support of laws to protect unborn children within the Federal District, including contacts in support of preservation of the "D.C. Hyde Amendment," a prohibition on the use of any congressionally appropriated funds (however labeled by local officials) for abortions (with certain exceptions) in the District of Columbia, in any FY 2017 continuing resolution and in any appropriations vehicle for FY 2018. Contacts in opposition to all ongoing efforts to evade constitutionally required congressional control over spending by the local administrative government of the Federal District, including District Council initiative to institute illegal expenditures of funds without congressional appropriation, in violation of the federal Anti-Deficiency Act and the Home Rule Act. Contacts in support of language in omnibus appropriations bill (H.R. 3354) to nullify local "budget autonomy" enactment, and in opposition to Norton Amendment to remove this provision (the House rejected the Norton Amendment, Sept. 14, 2017, and passed H.R. 3354).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
For activity pertaining to budget reconciliation legislation, see also the BUD (Budget/Appropriations) page. Contacts in support of certain provisions for incorporation into health care reform ("repeal and replace") legislation, including the Senate Better Care Replacement Act, including: elimination of multiple abortion-subsiding and abortion-expanding components of PL 111-148; inclusion of strong language to prevent federal subsidies of elective abortion coverage; retention of untaxed and uncapped private health insurance coverage, including postponement or nullification of the so-called "Cadillac tax" of PL 111-148; no limitation on what Americans can spend from private resources on health care; and strengthen provisions in PL 111-148 to enforce the segregation of funds for abortion services. Contacts regarding advance care planning legislation (not introduced) to (1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, (2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, (3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act, (4) include oversight for grant approval for physician orders for life-sustaining treatment, and (5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding potential legislation related to strengthening Federal policy against physician-assisted suicide. Contacts in support of H.Con.Res. 80, expressing the sense of the Congress that assisted suicide puts vulnerable patients at risk and undermines the integrity of the health care system. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts in support of strengthening regulations surrounding implementation of certain elements of PL 111-148 related to the segregation of funds for elective abortion. Contacts in support of H.R.4131 (Pittenger) to amend the Internal Revenue Code to impose federal taxes on bonds used to provide facilities owned by abortion providers. Contacts regarding the Protecting Access to Care Act of 2017 (H.R. 1215), pertaining to caps to damages arising from the intentional denial of treatment along with possible preemption issues related to state law; no position taken this quarter. Contacts in support of Protecting Seniors' Access to Medicare Act of 2017 (H.R.849/S.260) to repeal the Independent Payment Advisory Board, a component of PL 111-148 that has power to suppress nongovernmental health care spending by limiting treatments that doctors are allowed to give their patients.
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page. Contacts in support of the Medicare Choices Empowerment and Protection Act (S. 1530/H.R. 3181), to give beneficiaries and others online access to model advance directives that choose life-saving treatment, food and fluids equally with those that reject them in order to offset widespread efforts to nudge patients to agree to forego life-saving treatment.
Contacts in support of inclusion in budget reconciliation legislation (H.R. 1626 and Senate Better Care Reconciliation Act) provisions to (1) repeal and replace provisions of Public Law 111-148 ("Obamacare") that contain multiple abortion-subsidizing and abortion-expanding aspects; (2) incorporate certain tax provisions that facilitate coverage for lifesaving care in private health plans; (3) deny most federal funding for the Planned Parenthood Federation of America, the nation's largest abortion provider, and its affiliates; (4) strengthen provisions in PL 111-148 to enforce the segregation of funds for abortion services. This included a letter dated July 25, 2017 to the U.S. Senate urging a positive vote on the motion to proceed to debate. Contacts in support of inclusion in budget reconciliation legislation (H.R. 1626 and Senate Better Care Reconciliation Act) of amendments offered by Sen. Strange to extend "Hyde" protections to payments to insurers and by Sen. Heller to entirely remove the so-called "Cadillac Tax" on plans that facilitate coverage for lifesaving care. Contacts in support of S.Amdt.1030 to H.R.1628, referred to as the Graham-Cassidy-Heller-Johnson bill, to repeal and replace provisions of Public Law 111-148 ("Obamacare") that contain multiple abortion-subsidizing and abortion-expanding aspects, and would deny most federal funding for the Planned Parenthood Federation of America, the nation's largest abortion provider, and its affiliates. Contacts regarding H.R.244, the Consolidated Appropriations Act of 2017, in regards to funding of certain providers of abortion; no position taken on this legislation (but supported extension of all existing pro-life limitations and provisions from previous appropriations periods). Contacts in support of language to the FY 2018 State, Foreign operations appropriations bill (H.R. 3362) to create funding limitation on organizations that promote or perform abortion and organizations that participate in coercive abortion programs. Contacts in support of Harris Amendment to the FY 2018 Financial Services appropriations bill (H.R. 3280) to overturn the District of Columbia local law regarding physician-assisted suicide; adopted in House Appropriations Committee on July 13, 2017. Consultations in support of amendments to H.R 3354, the omnibus appropriations bill, including a letter to U.S. House members dated September 7, 2017, urging support of the Palmer Amendment to prohibit the District's local government from expending funds to enforce the RHNDA and urging rejection of the Norton Amendment to permit District officials to ignore congressional authority and open the door to funding of abortion, and contacts in support of retention of all current pro-life limitation amendments and other pro-life provisions.
Contacts in support of nomination of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Contacts advocating streamlining of committee and floor procedures for processing nominations. Consultations regarding legislation purporting to expand safe harbor for election-related speech by churches; no position on the legislation in the form introduced as the Free Speech Fairness Act (H.R. 781, S. 264).
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page. Contacts regarding the Healthy Kids Act (H.R. 3921), which reauthorizes the CHIP program with regards to blended risk pools for privately funded CHIP look-alike healthcare plans.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2018 continuing resolution and any other Foreign Operations appropriations vehicle. Contacts in support of nomination of pro-life ambassador to Haiti. Contacts in opposition to S. 210, to remove the authority of the President to apply certain conditions to U.S. funds directed to foreign nongovernmental organizations.
Contacts in opposition to H.J. Res. 33, S.J.Res.6, proposing to add certain language termed an "Equal Rights Amendment" to the U.S. Constitution, unless an "abortion-neutral amendment" is added. Contacts in opposition to H.J.Res 53, S.J.Res 5, resolutions embracing the erroneous concept that the long-dead 1972 "Equal Rights Amendment" can still be ratified by new states if Congress passes ex post facto legislation declaring inoperative the ratification deadline contained in the 1972 resolution.
For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (H.R. 36, S. 1922), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R.147), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 37, S. 220), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital. Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 644, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding Defund Planned Parenthood Act (H.R.853) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Defund Planned Parenthood Act (H.R. 354, S.241), to deny for one year the availability of federal funds to Planned Parenthood affiliates or clinics that provide elective abortion. Activity on budget reconciliation bill pertaining to Planned Parenthood reported on BUD (Budget/Appropriations) page. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in support of the Every Child is a Blessing Act (H.R. 684), to eliminate wrongful birth and wrongful life" lawsuits, when they arise under federal law or from claims involving health care services affecting interstate or foreign commerce. Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts expressing support for addition of language to prevent subsidies for abortion and other pro-life components in proposed legislation to revise laws dealing with health benefits for Peace Corps volunteers (H.R. 2259 and draft legislation in Senate). Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Patients First Act (H.R. 2918) to require the federal National Institutes of Health to intensify research on types of stem-cell research that do not involve harming human embryos. Responses to inquiries regarding "Life at Conception Act" (H.R. 681, S. 231); nonsupport due to lack of clarity and erroneous legal premises.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page.
For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (H.R. 36), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith, to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R.147), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 37, S. 220), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital. Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 644, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of the Title X Abortion Provider Prohibition Act (H.R.217), to prohibit funds under the federal Title X family planning program from going to entities (other than hospitals) that perform abortions (except to save the life of the mother, or in cases of rape or incest). Contacts regarding Defund Planned Parenthood Act (H.R.853) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Defund Planned Parenthood Act (H.R. 354, S.241), to deny for one year the availability of federal funds to Planned Parenthood affiliates or clinics that provide elective abortion. Activity on budget reconciliation bill pertaining to Planned Parenthood reported on BUD (Budget/Appropriations)page. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in support of the Every Child is a Blessing Act (H.R. 684), to eliminate wrongful birth and wrongful life" lawsuits, when they arise under federal law or from claims involving health care services affecting interstate or foreign commerce. Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts expressing support for addition of language to prevent subsidies for abortion and other pro-life components in proposed legislation to revise laws dealing with health benefits for Peace Corps volunteers (H.R. 2259 and draft legislation in Senate). Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Patients First Act (H.R. 2918) to require the federal National Institutes of Health to intensify research on types of stem-cell research that do not involve harming human embryos. Responses to inquiries regarding "Life at Conception Act" (H.R. 681, S. 231); nonsupport due to lack of clarity and erroneous legal premises.
Contacts in support of establishment of uniform Senate floor procedures (precedent) for consideration of judicial nominations, without regard to the level of court, including a letter to the Senate dated March 31, 2017 (precedent established, April 6, 2017). Contacts in support of the confirmation of Judge Neil Gorsuch as an associate justice of the United States Supreme Court, including a letter to the Senate dated March 31, 2017 (confirmed, April 7, 2017). Contacts in support of nomination of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Consultations regarding legislation purporting to expand safe harbor for election-related speech by churches; no position on the legislation in the form introduced as the Free Speech Fairness Act (H.R. 781, S. 264).
For activity pertaining to budget reconciliation legislation, see also the BUD (Budget/Appropriations) page. Contacts in support of certain provisions for incorporation into health care reform ("repeal and replace") legislation, including the Senate Better Care Replacement Act, including: elimination of multiple abortion-subsiding and abortion-expanding components of PL 111-148; inclusion of strong language to prevent federal subsidies of elective abortion coverage; retention of untaxed and uncapped private health insurance coverage, including postponement or nullification of the so-called "Cadillac tax" of PL 111-148; no limitation on what Americans can spend from private resources on health care; and strengthen provisions in PL 111-148 to enforce the segregation of funds for abortion services. Contacts regarding advance care planning legislation (not introduced) to (1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, (2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, (3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act, (4) include oversight for grant approval for physician orders for life-sustaining treatment, and (5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding potential legislation related to strengthening Federal policy against physician-assisted suicide. Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule. Contacts regarding the Protecting Access to Care Act of 2017 (H.R. 1215), pertaining to caps to damages arising from he intentional denial of treatment along with possible preemption issues related to state law; no position taken this quarter. Contacts in support of legislation to repeal the Independent Payment Advisory Board, a component of PL 111-148 that has power to suppress nongovernmental health care spending by limiting treatments that doctors are allowed to give their patients.
Contacts in support of inclusion in budget reconciliation legislation (H.R. 1626 and Senate Better Care Reconciliation Act) provisions to (1) repeal and replace provisions of Public Law 111-148 ("Obamacare") that contain multiple abortion-subsidizing and abortion-expanding aspects; (2) incorporate certain tax provisions that facilitate coverage for lifesaving care in private health plans; (3) deny most federal funding for the Planned Parenthood Federation of America, the nation's largest abortion provider, and its affiliates; (4) strengthen provisions in PL 111-148 to enforce the segregation of funds for abortion services. Contacts regarding H.R.244, the Consolidated Appropriations Act of 2017, in regards to funding of certain providers of abortion; no position taken on this legislation (but supported extension of all existing pro-life limitations and provisions from previous appropriations periods). Contacts in support of language to the FY 2018 State, Foreign operations appropriations bill (unnumbered) to create funding limitation on organizations that promote or perform abortion and organizations that participate in coercive abortion programs. Contacts in support of Harris Amendment to the FY 2018 Financial Services appropriations bill (unnumbered) to overturn the District of Columbia local law regarding physician-assisted suicide; adopted in House Appropriations Committee on July 13, 2017. Consultations regarding possible amendments for FY 2018 appropriations measures, including support for retention of all current pro-life limitation amendments and other pro-life provisions.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2018 continuing resolution and any other Foreign Operations appropriations vehicle. Contacts in support of nomination of pro-life ambassador to Haiti. Contacts in opposition to S. 210, to remove the authority of the President to apply certain conditions to U.S. funds directed to foreign nongovernmental organizations.
Insurance-related issues pertaining to reconciliation legislation are reported under BUD (Budget/Appropriations). Insurance-related provisions pertaining to health-care ("Obamacare replacement") legislation are reported on the HCR (Health Issues) page. Contacts in support of the Medicare Choices Empowerment and Protection Act (S. 1530 and draft legislation in House), to give beneficiaries and others online access to model advance directives that choose life-saving treatment, food and fluids equally with those that reject them in order to offset widespread efforts to nudge patients to agree to forego life-saving treatment.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
For activity pertaining to budget reconciliation legislation, see the BUD (Budget/Appropriations) page. Contacts in support of certain provisions for incorporation into health care reform ("repeal and replace") legislation, including: elimination of multiple abortion-subsiding and abortion-expanding components of PL 111-148; inclusion of strong language to prevent federal subsidies of elective abortion coverage; retention of untaxed and uncapped private health insurance coverage, including postponement or nullification of the so-called "Cadillac tax" of PL 111-148; and, no limitation on what Americans can spend from private resources on health care. Contacts in support of final version of American Health Care Act (H.R. 1628), including letter of March 17, 2017. Contacts regarding the addition of language to ensure a prohibition on the use of any congressionally appropriated funds for abortions including any credits or subsidies for plans that cover abortion (with certain exceptions) to the Obamacare Replacement Act (H.R. 1072, S.222). Contacts regarding the addition of language to ensure a prohibition on the use of any congressionally appropriated funds for abortions including any credits or subsidies for plans that cover abortion (with certain exceptions) to the Patient Freedom Act of 2017 (S.191). For activity pertaining to D.C. "Death with Dignity Act," see DOC (District of Columbia) page. Contacts regarding advance care planning legislation (not introduced) 1) ensure the legislation provides for adequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, 2) ensure that there are not Federally funded unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, 3) ensure that there are not adverse changes to the Assisted Suicide Funding and Restriction Act 4) include oversight for grant approval for physician orders for life-sustaining treatment and 5) protect the right of states to ensure informed consent in choosing and rejecting treatment. Contacts regarding legislation (not introduced) regarding potential legislation related to strengthening Federal policy against physician-assisted suicide. Contacts in the regarding potential CMS action in regards to the advance care planning services that have been added to the list of services in the Physician Fee Schedule payment rule.
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2017 continuing resolution and any other Foreign Operations appropriations vehicle. Contacts in support of executive action to establish limitations on funding of private organizations that perform or actively promote abortion in foreign nations, similar to the so-called "Mexico City Policy" that was in force during Republican administrations from 1984 on; support for presidential memorandum to secretary of state, secretary of health and human services, and administrator of USAID, January 23, 2017.
For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (H.R. 36), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R.147), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 37, S. 220),to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital. Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of actions by Members of Congress to call attention to refusal of DHHS, under the Obama Administration, to enforce the Weldon Amendment (prohibiting any level of government that receives DHHS funds from forcing participating in abortion) in the face of California's 2014 abortion-coverage mandate and other violations of the federal law. Contacts in support of the Conscience Protection Act (H.R. 664, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of H.J. Res. 43 (Black)(including letter to House dated February 10, 2017 and letter to Senate dated March 28, 2017), utilizing mechanism of Congressional Review Act to nullify 2016 DHHS regulation curbing ability of states to redirect funds under Title X of the Public Health Service Act. H.J. Res. 43 passed House Feb 16, 2017; passed Senate March 30, 2017; signed into law April 13, 2017. Contacts in support of companion bill S.J. Res. 13 (Ernst), and similar legislation H.J. Res. 39 (Messer). Contacts in support of the Title X Abortion Provider Prohibition Act (H.R.217), to prohibit funds under the federal Title X family planning program from going to entities (other than hospitals) that perform abortions (except to save the life of the mother, or in cases of rape or incest). Contacts regarding Defund Planned Parenthood Act (H.R.853) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Defund Planned Parenthood Act (H.R. 354, S.241), to deny for one year the availability of federal funds to Planned Parenthood affiliates or clinics that provide elective abortion. Activity on budget reconciliation bill pertaining to Planned Parenthood reported on BUD (Budget/Appropriations)page. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in support of the Every Child is a Blessing Act (H.R. 684), to eliminate wrongful birth and wrongful life" lawsuits, when they arise under federal law or from claims involving health care services affecting interstate or foreign commerce. Contacts regarding the Heartbeat Bill (H.R. 490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts expressing support for addition of language to prevent subsidies for abortion and other pro-life components in proposed legislation to revise laws dealing with health benefits for Peace Corps volunteers (draft legislation in House and Senate). Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans."
Contacts regarding the Midnight Rules Relief Act of 2017 (H.R. 21, S.34); no position taken. Contacts regarding the Regulations from the Executive in Need of Scrutiny Act of 2017 (H.R. 26, S.21); no position taken. Contacts in support of establishment of uniform Senate floor procedures (precedent) for consideration of judicial nominations, without regard to the level of court, including a letter to the Senate dated March 31, 2017 (precedent established, April 6, 2017). Contacts in support of the confirmation of Judge Neil Gorsuch as an associate justice of the United States Supreme Court, including a letter to the Senate dated March 31, 2017 (confirmed, April 7, 2017). Contacts in support of nomination of practitioners of judicial restraint to current and future vacancies on U.S. Courts of Appeals and federal district courts. Consultations regarding legislation purporting to expand safe harbor for election-related speech by churches; no position on the legislation in the form introduced as the Free Speech Fairness Act (H.R. 781, S. 264).
Contacts in opposition to H.J. Res. 33, S.J.Res.6, proposing to add certain language termed an "Equal Rights Amendment" to the U.S. Constitution, unless an "abortion-neutral amendment" is added. Contacts in opposition to H.J.Res 53, S.J.Res 5, resolutions embracing the erroneous concept that the long-dead 1972 "Equal Rights Amendment" can still be ratified by new states if Congress passes ex post facto legislation declaring inoperative the ratification deadline contained in the 1972 resolution.
Contacts in support of laws to protect unborn children within the Federal District, including contacts in support of preservation of the "D.C. Hyde Amendment," a prohibition on the use of any congressionally appropriated funds (however labeled by local officials) for abortions (with certain exceptions) in the District of Columbia, in any FY 2017 continuing resolution and in any appropriations vehicle for FY 2018. Contacts in opposition to all ongoing efforts to evade constitutionally required congressional control over spending by the local administrative government of the Federal District, including District Council initiative to institute illegal expenditures of funds without congressional appropriation, in violation of the federal Anti-Deficiency Act and the Home Rule Act. Contacts in support of H.J. Res. 27, S.J. Res 4 (including a letter to the House dated January 17, 2017), to nullify the actions of the D.C. Council pertaining to the "Death with Dignity Act" (B21-0038) and associated violations of the Assisted Suicide Funding Restriction Act of 1997, Pub. L. No. 105-12.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Contacts in support of laws to protect unborn children within the Federal District, including contacts in support of preservation of the "D.C. Hyde Amendment," a prohibition on the use of any congressionally appropriated funds (however labeled by local officials) for abortions (with certain exceptions) in the District of Columbia, in the FY 2017 Financial Services appropriations bill (H.R. 5485) and any other appropriations vehicle. Contacts in opposition to all ongoing efforts to evade constitutionally required congressional control over spending by the local administrative government of the Federal District, including District Council initiative to institute illegal expenditures of funds without congressional appropriation, in violation of the federal Anti-Deficiency Act and the Home Rule Act. Includes contacts in support of H.R. 5233 (Meadows), passed by the House May 25, 2016, establishing that the D.C. "budget autonomy" local law is null and void. Contacts in support of Palmer Amendment (no. 54) to Financial Services appropriations bill (H.R. 5485), adopted July 7, 2016, to prohibit expenditures to enforce local "Reproductive Health Nondiscrimination Act" (RHNDA). Contacts regarding potential legislation related to the actions of the D.C. Council pertaining to the "Death with Dignity Act" (B21-0038) and associated violations of the Assisted Suicide Funding Restriction Act of 1997, Pub. L. No. 105-12. National Right to Life opposes the "Death with Dignity Act" and favors congressional nullification.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Contacts in support of preservation into FY 2012 of the "D.C. Hyde Amendment," a prohibition on the use of any congressionally appropriated funds for abortions (with certain exceptions) in the District of Columbia. Contacts in support of possible legislation to extend and codify certain protections for unborn children (no bill introduced in this quarter).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care ratioining are reported under HCR (Health Issues).
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Contacts in support of legislation (not introduced) to repeal or revise certain components of Public Law 111-148 regarding the Independent Payment Advisory Boards authority to make recommendations, both in regards to government funded and private insurance, to slow the growth in national health expenditures below the rate of medical inflation. (continued) Oppose the authority of the Secretary of Health and Human Services or other Federal agencies to impose quality and efficiency measures that may be designed to limit what people spend in health care. Contacts in support of legislation (not introduced) to repeal or revise certain components of Public Law 111-148 regarding the authority of CMS to refuse to allow Medicare participants the choice of private-fee-for-service plans, which allow seniors to voluntarily add their own funds on top of the government contribution to obtain a plan less likely to deny care. Contacts in support of legislation (not introduced) to repeal or revise certain components of Public Law 111-148 regarding the authority of state health insurance exchanges administrators to limit premiums and plan values that insurers may offer inside and outside of the exchange should the insurer participate, having the effect of limiting what can be charged for health insurance, therefore restricting what people are allowed to pay for medical treatment. Contacts in support of legislation (not introduced) to repeal or revise certain components of Public Law 111-148 regarding shared decisionmaking due to lack of oversight, lack of balance in the materials and decision aids, and lack of safeguards in the creation of disseminating organization, which may lead to discouraging patients from seeking treatment. Contacts in response to inquiries regarding implementation of certain elements of Public Law 111-148 related to the denial of life-saving medical treatments. Contacts in response to inquiries regarding Medicare regulation, CMS-2010-0205-1983, which would provide for end-of-life counseling during annual visits. U.S. House of Representatives only: Contacts in regards to H.R. 4529 (111th Cong.), Roadmap for Americas Future Act, regarding concerns over authority of a Health Care Services Commissions ability to restrict access to life-saving care; regarding concerns over premium price controls that might reduce the ability of insurance to cover expensive life-saving care; and regarding malpractice limits being made applicable to intentional denial of treatment, denied for discriminatory reasons.
Contacts in support of H.R. 5111/S. 3723 (popularly known as the "Protect Life Act"), to override authorizations for abortion subsidies created by PL 111-148). Contacts in support of H.R. 5939 (No Taxpayer Funding of Abortion Act), to establish permanent government-wide prohibition on abortion subsidies, and inclusion of support for H.R. 5939 in agenda for action for the 112th Congress. Contacts on general organizational matters (continued) pertaining to House Energy & Commerce Committee for 112th Congress. Contacts regarding abortion-related policy issues pertaining to H.R. 4529 (Roadmap for America's Future Act of 2010). Contacts regarding legal and policy issues raised by providing of "telemed abortions" by federally funded entities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
U.S. Senate Contacts in effort to oppose measures that could enable the rationing of health care; supported the addition of a variable financing method to avoid rationing. (continued) On potential merger of Senate H.R. 3590, the Patient Protection and Affordable Care Act, with H.B. 3962, the Affordable Health Care for America Act contacts in support of addition of variable withhold financing method to avoid rationing. Contacts in support of the Senates anti-discrimination language as it related to Comparative Effectiveness Research. Contacts in support of extending the Senates comparative effectiveness anti-discrimination language to other places in the legislation where the Secretary is given authority to determine quality and efficiency. Contacts in opposition to the inclusion of either the House or Senate Advance Care planning provisions which contains disincentive for balanced counseling and incentives to steer them toward rejection of treatment, including life-preserving treatment, lacks representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life, and lacks continuing oversight. Contacts to oppose further changes relating to advance care planning which would make changes to Assisted Suicide Funding Restriction Act of 1997. Contacts in support of conscience protection that does not extend to protecting providers against denial of medical care to an individual because of the individuals age, disability, or other characteristic. Contacts to ensure that taxpayer funds do not support of fund physician assisted suicide. Contacts in opposition to the Senate Independent Medicare Advisory Boards power to recommend, and the Secretary of Health and Human Services to impose, requirements for insurance plans in the exchanges that would have the effect of limiting Americans right to spend their own money, if they choose, to save their own lives. Contacts in opposition to the Senate bills Independent Payment Advisory Board authority to make cuts in Medicare. Contacts in opposition to the Senate provisions wherein Commissioners of the State Health Insurance Exchanges are given discretion to impose price controls on insurance premiums under Section 1003 thus limiting access to plans able to provide unrationed care. Contacts in opposition to H.B. 3962s section 3209s grant of discretion to CMS to deny older Americans the choice of plans whose premiums CMS deems too high thus limiting access to plans able to provide unrationed care). Contacts in opposition to the inclusion of concepts from the February 22, 2010 Obama Administration health care proposal which would have imposed premium price controls on private plan and denied senior citizens their current right to add their own money on top of the government Medicare contribution to get health insurance less likely to deny treatment through tightly controlled managed care. (continued) U.S. House of Representatives Contacts in effort to oppose measures that could enable the rationing of health care; supported the addition of a variable financing method to avoid rationing. On potential merger of Senate H.R. 3590, the Patient Protection and Affordable Care Act, with H.B. 3962, the Affordable Health Care for America Act contacts in support of addition of variable withhold financing method to avoid rationing. Contacts in support of the Senates anti-discrimination language as it related to Comparative Effectiveness Research. Contacts in support of extending the Senates comparative effectiveness anti-discrimination language to other places in the legislation where the Secretary is given authority to determine quality and efficiency. Contacts in opposition to the inclusion of either the House or Senate Advance Care planning provisions which contains disincentive for balanced counseling and incentives to steer them toward rejection of treatment, including life-preserving treatment, lacks representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life, and lacks continuing oversight. Contacts to oppose further changes relating to advance care planning which would make changes to Assisted Suicide Funding Restriction Act of 1997. Contacts in support of conscience protection that does not extend to protecting providers against denial of medical care to an individual because of the individuals age, disability, or other characteristic. Contacts to ensure that taxpayer funds do not support of fund physician assisted suicide. Contacts in opposition to the Senate Independent Medicare Advisory Boards power to recommend, and the Secretary of Health and Human Services to impose, requirements for insurance plans in the exchanges that would have the effect of limiting Americans right to spend their own money, if they choose, to save their own lives. Contacts in opposition to the Senate bills Independent Payment Advisory Board authority to make cuts in Medicare. Contacts in opposition to the Senate provisions wherein Commissioners of the State Health Insurance Exchanges are given discretion to impose price controls on insurance premiums under Section 1003 thus limiting access to plans able to provide unrationed care. Contacts in opposition to H.B. 3962s section 3209s grant of discretion to CMS to deny older Americans the choice of plans whose premiums CMS deems too high thus limiting access to plans able to provide unrationed care). Contacts in opposition to the inclusion of concepts from the February 22, 2010 Obama Administration health care proposal, which would have imposed premium price controls on private plans and denied senior citizens their current right to add their own money on top of the government Medicare contribution to get health insurance less likely to deny treatment through tightly controlled managed care. Contacts expressing general concerns about denial of treatment and rationing provisions in H.R. 4529, the "Roadmap for America's Future Act" including: 1. The possibility of the health care services commissions dictation of the practice of medicine, 2. The inadequate protection of the use of discriminatory criteria in comparative effectiveness research, 3. The inconsistency in rejection of premium price controls, and 4. clarification that malpractice reform limitations ought not to apply to intentional discriminatory denial of life-preserving treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
On Medicare Improvements for Patients and Providers Act of 2008 (H.R. 6331), Section 162, answered inquiries to provide assurance we were not opposing the bill. On Senator Max Baucus' "Call to Action [:] Health Reform 2009" [commonly known as "Baucus White Paper on Health Reform"], Healthy Americans Act (S> 334), and health care reform generally, opposed rationing of health care, supported addition of variable withhold financing method to avoid rationing, analysis of abortion mandates (continued) and revisions to avoid enactment of abortion mandates. On Comparative Effectiveness Research Act of 2008 [S. 3408), ation regarding comparative effectiveness standards in Medicare, worked to ensure that patient's competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
On Medicare Improvements for Patients and Providers Act of 2008 (S. 3101), opposed rationing of Medicare through curtailing the private fee-for-service option. (continued) We worked to modify Section 163s provision relating to quality reporting to make it feasible for private fee-for-service plans. On Medicare Improvements for Patients and Providers Act of 2008 (H.R. 6331), Section 162, answered inquiries to provide assurance we were not opposing the bill. On Healthy Americans Act (S. 334), opposed rationing of health care, supported addition of variable withhold financing method to avoid rationing, analysis of abortion mandates and revisions to avoid enactment of abortion mandates. On contemplated legislation regarding comparative effectiveness standards in Medicare, worked to ensure that patient's competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes. On potential legislation to require the government to negotiate the price of prescription drugs in Medicare, explained our opposition.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
On contemplated legislation restructuring Medicare Advantage, opposed rationing of Medicare through curtailing private fee-for-service option.
Supported Discharge Petition No. 3 on HR 2905, to prohibit reimposition of so-called "Fairness Doctrine." Supported HR 618, responded to inquiries regarding legal effects of HR 1094, HR 2597. Supported civil rights of medically dependent and disabled, and related legal principles.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
Opposed SJR 10 and HJR 40 ("Women's Equality Amendment" or "Equal Rights Amendment") unless revised by adoption of Sensenbrenner abortion-neutral amendment. Responded to inquiries regarding other proposed constitutional amendments that would affect abortion policy.
Supported civil rights of medically dependent and disabled, and related legal principles. Opposed proposals to place restrictions on communications to the public about events in Congress; opposed H.R. 2093 (Meehan-Shays) and Meehan Amendment to H.R. 2316. Opposed proposals to amend H.R. 2316/S.1 to require reporting of donors/members' contributions. (continued)
Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Supported ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.
Opposed proposals to place restrictions on communications to the public about events in Congress; opposed H.R. 2093 (Meehan-Shays) and Meehan Amendment to H.R. 2316. Opposed proposals to amend H.R. 2316/S.1 to require reporting of donors/members. Opposed duplicative reporting requirements in these bills. Opposed H.R. 984, "Executive Branch Reform Act." Supported Coleman Amendment (Innocent Child Protection) to HR 1585 and HR 2669, (continued)
On SCHIP reauthorization bills (HR 976, HR 3162, HR 3963, S. 2499) and related drafts, substitutes, and amendments: (1) opposed rationing of Medicare through curtailing private fee-for-service option; and (2) supported codification of regulation allowing states to cover "unborn child" (Allard Amendment No. 2535, Pitts Amendment). Responded to inquiries on HR 1074 (Ryan-DeLauro); opposed language undermining SCHIP "unborn child" rule and certain other provisions. Analysis (continued)
Supported S. 561, HR 471 (Adoption Tax Relief Guarantee Act).
Supported retention of pro-life provisions of FY 2008 appropriations bills, including: HR 2764 (State-Foreign Operations), opposed Lowey language to gut "Mexico City Policy" and supported Smith-Stupak Amendment to remove; opposed Boxer amendment to overturn Mexico City Policy and supported Brownback Amendment no. 2708. Opposed Leahy language to gut Kemp-Kasten anti-coercion law and MCP; supported Brownback amendment no. 2707 to restore Kemp-Kasten language. (continued)
Supported Vitter Amendment to S. 1200 and Pitts Amendment to HR 1328, Indian health reauthorization bills, to codify prohibition on coverage of abortion in federal Indian health programs (except in cases of life of the mother, rape, and incest).
Supported HR 1063 (Child Interstate Abortion Notification Act). Advisory discussions re: legislation consistent with Supreme Court ruling in Gonzales v. Carhart. Supported the civil rights of medically dependent and disabled persons, and related legal principles. Supported Coleman Amendment (Innocent Child Protection Amendment) to HR 1585 and HR 2669.
Supported HR 1088 and S. 915, Elizabeth Cady Stanton Pregnant and Parenting Student Services Act.
Supported prohibition on funding of abortion by D.C. city government in HR 2829 (Financial Services Appropriations bill), and opposed HR 733, a bill that would nullify this limitation amendment, unless revised by adoption of Jordan Amendment to HR 733. Discussion of constitutional implications of HR 1433 and S. 1257 (granting voting status to non-State federal enclave) and possible amendments thereto relating to abortion funding policy.
Supported HR 1063 (Child Interstate Abortion Notification Act), S. 2075 (Ultrasound Informed Consent Act). Supported S. 356 and HR 3442 (Unborn Child Pain Awareness Act). Supported S. 350 (Abortion Non-Discrimination Act). Supported veto and sustaining of veto of any bill that weakens any existing pro-life policy. Opposed S. 1173, HR 1964 ("Freedom of Choice Act"). Advised re: abortion-related (cont.)
On SCHIP reauthorization bills (HR 976, HR 3162, HR 3963, S. 2499) and related drafts, substitutes, and amendments: (1) opposed rationing of Medicare through curtailing private fee-for-service option; and (2) supported codification of regulation allowing states to cover "unborn child" (Allard Amendment No. 2535, Pitts Amendment). Responded to inquiries on HR 1074 (Ryan-DeLauro); opposed language undermining SCHIP "unborn child" rule and certain other provisions.
On Genetic Information Nondiscrimination Act (GINA), HR 493, supported revisions to prevent discrimination against adoptive families and unborn children.
Opposed ratification of Convention on the Elimination of All Forms of Discrimination Against Women (CEDAW), and H Res 101 (endorsing such ratification). Opposed Lowey language to HR 2764 to gut "Mexico City Policy," and supported Smith-Stupak Amendment to remove this language. Opposed Boxer Amendment to HR 2764 to overturn the Mexico City Policy, (continued)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
On Genetic Information Nondiscrimination Act (GINA), HR 493, supported revisions to prevent discrimination against adoptive families and unborn children.
On SCHIP reauthorization (HR 3162, Senate Finance Committee substitute to HR 976, other substitutes), opposed rationing of Medicare through curtailing private fee-for-service option. Opposed HR 4/S.5 due to provisions imposing price controls that would limit access to and discourage the development of innovative life-saving medicines.
Rees as asst. secretary of State. Opposed ratification of Convention for the Elimination of All Forms of Discrimination Against Women (CEDAW), and H Res 101 (endorsing such ratification). Opposed Lowey language to HR 2764 to gut "Mexico City Policy," and supported Smith-Stupak Amendment to remove this language; opposed Leahy language in HR 2764 to gut "Mexico City Policy" and Kemp-Kasten anti-coercion law. Opposed HR 2604 (to gut Kemp-Kasten law and fund the UNFPA). Endorsement of G.J. (cont.)
Supproted HR 1088, Elizabeth Cady Stanton Pregnant and Parenting Students Act.
Opposed SJR 10 and HJR 40 ("Women's Equality Amendment" or "Equal Rights Amendment") unless revised by adoption of Sensenbrenner abortion-neutral amendment. Responded to inquiries regarding other proposed constitutional amendments that would affect abortion policy.
Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Support ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.
Opposed proposals to place restrictions on communications to the public about events in Congress; supported Bennett Amendment to S. 1; opposed H.R. 2093 (Meeehan-Shays) and Meehan Amendment to H.R. 2316. Opposed proposals to amend H.R. 2316/S.1 to require reporting of donors/members. Opposed H.R. 984, "Executive Branch Reform Act," a proposal to require reporting into government database of communications from the public to political appointees. (continued) Supported Broadcaster Freedom Act (HR. 2905, S. 1742), and Pence Amendment to H.R. 2829, to prohibit enforcement of "Fairness Doctrine." Regarding Genetic Information Nondiscrimination Act (HR 493), supported revisions to prevent discrimination against unborn children and adoptive families. Supported HR 618. Responded to inquiries regarding HR 1094.
Supported civil rights of medically dependent and disabled, and related legal principles. Opposed proposals to place restrictions on communications to the public about events in Congress; supported Bennett Amendment to S. 1; opposed H.R. 2093 (Meehan-Shays) and Meehan Amendment to H.R. 2316. Opposed proposals to amend H.R. 2316/S.1 to require reporting of donors/members. (continued) Opposed HR 984, "Executive Branch Reform Act," a proposal to require reporting into government database of communications from the public to political appointees. Supported Broadcaster Freedom Act (HR 2905, S. 1742), and Pence Amendment to H.R. 2829, to prohibit enforcement of "Fairness Doctrine." Offered technical comments regarding HR 170. Opposed HR 733 (DC budget autonomy) unless revised with Jordan Amendment to bar funding of abortion. Discussed constitutional implications of HR 1433/S. 1257, purporting to grant voting status to non-State federal enclave.
"Fairness Doctrine." HR 3093, Commerce-Justice-Science, supported abortion-related provisions pertaining to Bureau of Prisons and Legal Services Corporation, Weldon Amendment pertaining to patenting of human organisms. HR 3043, Labor-HHS-Education, supported provisions barring federal funding of abortion and embryo-killing research, and prohibiting discrimination against health care providers to decline to participate in providing abortion. Supported vetoes and sustaining of vetos on any bills that would weaken or remove any existing prolife provisions. Supported retention of pro-life provisions of FY 2008 appropriations bills, including: HR 2764 (State-Foreign Operations), oppose Lowey language to gut "Mexico City Policy" and support Smith-Stupak Amendment to remove; opposed Leadhy language to gut "Mexico City Policy" and Kemp-Kasten anti-coercion law. HR 2829, Financial Serivces: prohibition on FEHBP abortion coverage and funding of abortions by D.C. city government; support Pence Amendment to bar FCC from reinstating (cont.)
Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Supported ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.
Supported S. 561, HR 471 (Adoption Tax Relief Guarantee Act). Responded to inquiry re: tax deduction status of abortion.
On SCHIP reauthorization (HR 3162, Senate Finance Committee substitute to HR 976, other substitutes): (1) opposed rationing of Medicare through curtailing private fee-for-service option; (2) supported codification of regulation allowing states to cover "unborn child." Responded to inquiries on HR 1074 (Ryan-DeLauro); opposed language undermining SCHIP "unborn child" rule and certain other provisions. Technical discussion of HR 211 provisions. Opposed S. 3/HR 4 due to provisions imposing price controls (cont.) that would limit access to and discourage the development of innovative life-saving medicines.
Supported HR 1063 (Child Interstate Abortion Notification Act). Advisory discussions re: legislation consistent with Supreme Court ruling in Gonzales v. Carhart. Supported for the civil rights of medically dependent and disabled persons, and related legal principles. Advisory discussions regarding amendments or potential amendments to HR 137, S. 261 (Animal Fighting Prohibition Enforcement Act)(took no position on the bill).
Opposed possible pro-abortion amendments to defense authorization bill (HR 1585).
Filing targets: Air Force, Dept of, Army, Dept of (Other), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Navy, Dept of, Office of the Vice President of the United States, SENATE, State, Dept of (DOS)
Opposed possible pro-abortion amendments to defense authorization bill (HR 1585).
On SCHIP reauthorization (HR 3162, Senate Finance Committee substitute to HR 976, other substitutes), opposed rationing of Medicare through curtailing private fee-for-service option. Opposed HR 4/S.5 due to provisions imposing price controls that would limit access to and discourage the development of innovative life-saving medicines.
"Fairness Doctrine." HR 3093, Commerce-Justice-Science, supported abortion-related provisions pertaining to Bureau of Prisons and Legal Services Corporation, Weldon Amendment pertaining to patenting of human organisms. HR 3043, Labor-HHS-Education, supported provisions barring federal funding of abortion and embryo-killing research, and prohibiting discrimination against health care providers to decline to participate in providing abortion. Supported vetoes and sustaining of vetos on any bills that would weaken or remove any existing prolife provisions. Supported retention of pro-life provisions of FY 2008 appropriations bills, including: HR 2764 (State-Foreign Operations), oppose Lowey language to gut "Mexico City Policy" and support Smith-Stupak Amendment to remove; opposed Leadhy language to gut "Mexico City Policy" and Kemp-Kasten anti-coercion law. HR 2829, Financial Serivces: prohibition on FEHBP abortion coverage and funding of abortions by D.C. city government; support Pence Amendment to bar FCC from reinstating (cont.)
legislation consistent with Supreme Court ruling in Gonzales v. Carhart. Supported HR 457 (to promote research into post-abortion depression, etc.), and supported proposal to add comparable provisions to HR 20. Supported HR 223 (Informed Choice Act), and advised re: formulation of additional ultrasound-related legislation. Supported HR 1063 (Child Interstate Abortion Notification Act), S. 356 and HR 3442 (Unborn Child Pain Awareness Act). Supported S. 350 (Abortion Non-Discrimination Act). Supported S. 351 (Title X reform). Supported veto and sustaining of veto of any bill that weakens any existing pro-life policy. Opposed S. 1173, HR 1964 ("Freedom of Choice Act"). Advised re: abortion-related (cont.)
Supported HR 1063 (Child Interstate Abortion Notification Act). Advisory discussions re: legislation consistent with Supreme Court ruling in Gonzales v. Carhart. Supported for the civil rights of medically dependent and disabled persons, and related legal principles. Advisory discussions regarding amendments or potential amendments to HR 137, S. 261 (Animal Fighting Prohibition Enforcement Act)(took no position on the bill).
Supproted HR 1088, Elizabeth Cady Stanton Pregnant and Parenting Students Act.
Opposed SJR 10 and HJR 40 ("Women's Equality Amendment" or "Equal Rights Amendment") unless revised by adoption of Sensenbrenner abortion-neutral amendment. Responded to inquiries regarding other proposed constitutional amendments that would affect abortion policy.
On SCHIP reauthorization (HR 3162, Senate Finance Committee substitute to HR 976, other substitutes): (1) opposed rationing of Medicare through curtailing private fee-for-service option; (2) supported codification of regulation allowing states to cover "unborn child." Responded to inquiries on HR 1074 (Ryan-DeLauro); opposed language undermining SCHIP "unborn child" rule and certain other provisions. Technical discussion of HR 211 provisions. Opposed S. 3/HR 4 due to provisions imposing price controls (cont.) that would limit access to and discourage the development of innovative life-saving medicines.
Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Supported ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.
On Genetic Information Nondiscrimination Act (GINA), HR 493, supported revisions to prevent discrimination against adoptive families and unborn children.
Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Support ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.
Supported civil rights of medically dependent and disabled, and related legal principles. Opposed proposals to place restrictions on communications to the public about events in Congress; supported Bennett Amendment to S. 1; opposed H.R. 2093 (Meehan-Shays) and Meehan Amendment to H.R. 2316. Opposed proposals to amend H.R. 2316/S.1 to require reporting of donors/members. (continued) Opposed HR 984, "Executive Branch Reform Act," a proposal to require reporting into government database of communications from the public to political appointees. Supported Broadcaster Freedom Act (HR 2905, S. 1742), and Pence Amendment to H.R. 2829, to prohibit enforcement of "Fairness Doctrine." Offered technical comments regarding HR 170. Opposed HR 733 (DC budget autonomy) unless revised with Jordan Amendment to bar funding of abortion. Discussed constitutional implications of HR 1433/S. 1257, purporting to grant voting status to non-State federal enclave.
Rees as asst. secretary of State. Opposed ratification of Convention for the Elimination of All Forms of Discrimination Against Women (CEDAW), and H Res 101 (endorsing such ratification). Opposed Lowey language to HR 2764 to gut "Mexico City Policy," and supported Smith-Stupak Amendment to remove this language; opposed Leahy language in HR 2764 to gut "Mexico City Policy" and Kemp-Kasten anti-coercion law. Opposed HR 2604 (to gut Kemp-Kasten law and fund the UNFPA). Endorsement of G.J. (cont.)
Supported prohibition on funding of abortion by D.C. city government in HR 2829 (Financial Services Appropriations bill), and opposed HR 733, a bill that would nullify this limitation amendment, unless revised by adoption of Jordan Amendment to H.R. 733. Discussion of constitutional implications of HR 1433 and S. 1257 (granting voting status to non-State federal enclave).
Filing targets: Air Force, Dept of, Army, Dept of (Other), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Navy, Dept of, Office of the Vice President of the United States, SENATE, State, Dept of (DOS)